Variations of Serum E2 and P4 Levels
血清铁蛋白参考区间建立的英文文献
血清铁蛋白参考区间建立的英文文献The Establishment of Serum Ferritin Reference IntervalIron is an essential mineral that plays a crucial role in various physiological processes within the human body. It is a vital component of hemoglobin, the protein responsible for transporting oxygen in the bloodstream, and is also involved in the functioning of numerous enzymes. Adequate iron levels are necessary for maintaining healthy red blood cell production, cognitive function, and immune system function.Serum ferritin is a widely used biomarker for assessing an individual's iron status. Ferritin is a protein that stores iron within cells, and its concentration in the blood reflects the body's total iron stores. Determining the appropriate reference interval for serum ferritin is crucial for accurately interpreting an individual's iron status and identifying potential iron deficiency or overload.The establishment of a reliable serum ferritin reference interval is a complex process that involves several considerations. Factors such as age, gender, ethnicity, and underlying medical conditions can all influence an individual's normal range of serum ferritin. Additionally,pre-analytical and analytical variables, such as sample collection, processing, and laboratory methodology, can also impact the reported values.One of the primary challenges in establishing a serum ferritin reference interval is the lack of a universally accepted standard. Different laboratories and clinical guidelines may use different reference ranges, which can lead to inconsistencies in the interpretation of results. This lack of standardization can be particularly problematic when comparing results across different healthcare settings or when monitoring an individual's iron status over time.To address this issue, several studies have been conducted to develop and validate serum ferritin reference intervals that are representative of the target population. These studies typically involve the collection of samples from a large, well-characterized cohort of healthy individuals, with careful consideration of potential confounding factors.One such study, published in the Journal of Clinical Laboratory Analysis, aimed to establish serum ferritin reference intervals for a Korean population. The researchers recruited 1,014 healthy adults, aged 20 to 69 years, and collected blood samples for serum ferritin analysis. They stratified the data by age and gender, and calculatedthe reference intervals using statistical methods recommended by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).The results of this study showed that the serum ferritin reference interval for Korean adults was 15.0-336.2 μg/L for men and 10.0-153.0 μg/L for women. These values were notably different from the reference intervals commonly used in clinical practice, which were typically based on data from Western populations.Another study, published in the Annals of Clinical Biochemistry, focused on establishing serum ferritin reference intervals for a Chinese population. The researchers recruited 1,800 healthy adults, aged 18 to 80 years, and analyzed their serum ferritin levels. They found that the reference intervals were 30.0-400.0 μg/L for men and 13.0-204.0 μg/L for women.These studies highlight the importance of developing population-specific reference intervals for serum ferritin. Relying on reference ranges derived from other populations may lead to misinterpretation of an individual's iron status, potentially resulting in inappropriate clinical management.In addition to establishing reference intervals, researchers have also explored the factors that can influence serum ferritin levels. Forexample, a study published in the European Journal of Haematology examined the impact of age and gender on serum ferritin in a large cohort of healthy individuals.The researchers found that serum ferritin levels increased with age in both men and women, with the most significant increase observed after the age of 50 years. They also observed that serum ferritin levels were generally higher in men compared to women, likely due to differences in body composition and hormonal factors.Furthermore, studies have investigated the impact of other factors, such as obesity, inflammation, and genetic variations, on serum ferritin levels. Understanding these factors is crucial for interpreting serum ferritin results and ensuring accurate diagnosis and management of iron-related disorders.In conclusion, the establishment of reliable serum ferritin reference intervals is essential for the accurate assessment of an individual's iron status. The development of population-specific reference intervals, taking into account factors such as age, gender, and ethnicity, can help improve the clinical interpretation of serum ferritin results and guide appropriate medical interventions. Ongoing research in this field continues to enhance our understanding of the complex factors that influence serum ferritin and contribute to the optimization of iron management in clinical practice.。
胆汁酸谱在肺炎和肺癌鉴别诊断中的应用价值
文章编号:1673-8640(2021)01-001-07 中图分类号:R446.1 文献标志码:A DOI:10.3969/j.issn.1673-8640.2021.01.001胆汁酸谱在肺炎和肺癌鉴别诊断中的应用价值徐润灏1,邹 琛1,张 洁2,李 敏2,张舒林1(1.上海交通大学医学院,上海 200025;2.上海交通大学医学院附属仁济医院检验科,上海 200001)摘要:目的探讨肺癌患者血清胆汁酸谱的变化及其在肺炎与肺癌鉴别诊断中的价值。
方法 采用液相色谱-串联质谱法(LC-MS/MS)检测80例肺炎患者(肺炎组)、108例肺癌患者(肺癌组)和106名体检健康者(正常对照组)血清胆汁酸谱[5种游离胆汁酸,包括胆酸(CA)、鹅脱氧胆酸(CDCA)、脱氧胆酸(DCA)、石胆酸(LCA)、熊脱氧胆酸(UDCA);10种结合胆汁酸,包括甘氨胆酸(GCA)、甘氨鹅脱氧胆酸(GCDCA)、甘氨脱氧胆酸(GDCA)、甘氨石胆酸(GLCA)、甘氨熊脱氧胆酸(GUDCA)、牛磺胆酸(TCA)、牛磺鹅脱氧胆酸(TCDCA)、牛磺脱氧胆酸(TDCA)、牛磺石胆酸(TLCA)、牛磺熊脱氧胆酸(TUDCA)],同时检测血清总胆汁酸(TBA)及肿瘤标志物[糖类抗原(CA)125、CA19-9、癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA 21-1)、神经元特异性烯醇化酶(NSE)]。
采用二元Logistic回归分析筛选指标并建立诊断模型。
采用受试者工作特性(ROC)曲线分析各项指标及诊断模型鉴别诊断肺炎与肺癌的效能。
结果与正常对照组比较,肺炎组血清游离胆汁酸DCA、LCA、UDCA水平及结合胆汁酸GDCA、GLCA、TDCA、TLCA水平降低(P<0.01),血清结合胆汁酸GCDCA、TCDCA水平升高(P<0.01);肺癌组血清游离胆汁酸CA、CDCA水平及结合胆汁酸GCDCA、TCDCA水平升高(P<0.01),血清结合胆汁酸TDCA、TLCA水平降低(P<0.01)。
乳样保存条件对乳尿素氮浓度测定的影响
乳样保存条件对乳尿素氮浓度测定的影响摘要:研究了3种常用的防腐剂(重铬酸钾、苯甲酸钠和山梨酸钾)以及室温、冷藏和冷冻等3种不同温度的保存条件对牛奶中乳尿素氮浓度测定的影响。
结果表明,添加常规剂量和加倍剂量重铬酸钾乳样的尿素氮浓度与原乳样差异不显著(P>0.05),而添加行业标准量及加倍剂量苯甲酸钠、山梨酸钾的乳样中乳尿素氮浓度显著高于原乳样(P<0.05);室温和冷藏温度条件下随保存时间的延长,原乳样乳尿素氮浓度迅速降低,而冷冻保存条件下原乳样乳尿素氮浓度基本不变;添加重铬酸钾的乳样在室温、冷藏和冷冻条件下,随着保存时间的延长乳尿素氮浓度均无明显变化。
乳样收集后若不能及时测定乳尿素氮浓度,建议添加重铬酸钾防腐剂,未添加重铬酸钾时冷冻保存。
关键词:乳尿素氮;乳样;防腐剂;温度条件中图分类号:O657.32;TS252.26 文献标识码:A文章编号:0439-8114(2011)18-3828-03EffectofPreservationConditionsontheConcentrationofMilkUreaNitrogenLINWen-yan,ZHAIShao-wei,CHENGShi-ming(KeyLaboratoryofScienceandTechnologyforAquacultureandFoodSafetyofFujianProvinceUniversity/ FisheriesCollegeofJimeiUniversity,Xiamen361021,Fujian,China)Abstract:Theimpacts ofthreecommonlyusedpreservatives(potassiumdichromate,sodiumbenzoate,potassiumsorbate)atdifferenttemperatures (roomtemperature,chilledandfrozen)onthedeterminationofthe concentrationof milkureanitrogen(MUN)were studiedcomparatively.Theresultsshowedthatthpotassiumdichromateofconventionaldoseordoublingdosehad nosignificantdifferencewiththeoriginalmilksample(P>0.05),theconcentrationofMUNwithsodiumbenzoateandpotassiumsorbateofconventionaldoseordoublingdosewassignificantlyhigherthantheoriginalmilksample(P<0.05),preservationat roomtemperatureor chilledwouldmakethe concentrationofMUNreducerapidly withthetimeextended,preservationat frozenwouldmadethe concentrationofMUNremainintheinitiallevel,themilksamplewithpotassiumatroomtemperature,chilledandfrozenconditions,thesignificantchange.Oncethesamplecouldnotbeanalyzedimmediatelyafterbeingcollected,it was proposed that thepotassiumdichromatetobe addedorfrozenmethodto be used when the potassium dichromate wasn’t added.Keywords:milkureanitrogen;milksample;preservative;temperature牛乳中,尿素是非蛋白氮的主要来源,约占全部牛乳中所含氮的5%,其余95%为真蛋白质[1]。
marked manuscript
Quality evaluation of Flos Lonicerae through a simultaneous determination of seven saponins by HPLC with ELSDXing-Yun Chai1, Song-Lin Li2, Ping Li1*1Key Laboratory of Modern Chinese Medicines and Department of Pharmacognosy, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China2Institute of Nanjing Military Command for Drug Control, Nanjing, 210002, People’s Republic of China*Corresponding author: Ping LiKey Laboratory of Modern Chinese Medicines and Department of Pharmacognosy, China Pharmaceutical University, Nanjing 210009, People’s Republic of China.E-mail address: lipingli@Tel.: +86-25-8324-2299; 8539-1244; 135********Fax: +86-25-8532-2747AbstractA new HPLC coupled with evaporative light scattering detection (ELSD) method has been developed for the simultaneous quantitative determination of seven major saponins, namely macranthoidinB (1), macranthoidin A (2), dipsacoside B (3), hederagenin-28-O-β-D-glucopyranosyl(6→1)-O-β-D- glucopyranosyl ester (4), macranthoside B (5), macranthoside A (6), and hederagenin-3-O-α-L-arabinopyranosyl(2→1)-O-α-L-rhamnopyranoside (7)in Flos Lonicerae, a commonly used traditional Chinese medicine (TCM) herb.Simultaneous separation of these seven saponins was achieved on a C18 analytical column with a mixed mobile phase consisting of acetonitrile(A)-water(B)(29:71 v/v) acidified with 0.5% acetic acid. The elution was operated from keeping 29%A for 10min, then gradually to 54%B from 10 to 25 min on linear gradient, and then keep isocratic elution with 54%B from 25 to 30min.The drift tube temperature of ELSD was set at 106℃, and with the nitrogen flow-rate of 2.6 l/min. All calibration curves showed good linear regression (r2 0.9922) within test ranges. This method showed good reproducibility for the quantification of these seven saponins in Flos Lonicerae with intra- and inter-day variations of less than 3.0% and 6.0% respectively. The validated method was successfully applied to quantify seven saponins in five sources of Flos Lonicerae, which provides a new basis of overall assessment on quality of Flos Lonicerae.Keywords: HPLC-ELSD; Flos Lonicerae; Saponins; Quantification1. IntroductionFlos Lonicerae (Jinyinhua in Chinese), the dried buds of several species of the genus Lonicera (Caprifoliaceae), is a commonly used traditional Chinese medicine (TCM) herb. It has been used for centuries in TCM practice for the treatment of sores, carbuncles, furuncles, swelling and affections caused by exopathogenic wind-heat or epidemic febrile diseases at the early stage [1]. Though four species of Lonicera are documented as the sources of Flos Lonicerae in China Pharmacopeia (2000 edition), i.e. L. japonica, L. hypoglauca,L. daystyla and L. confusa, other species such as L. similes and L. macranthoides have also been used on the same purpose in some local areas in China [2]. So it is an important issue to comprehensively evaluate the different sources of Flos Lonicerae, so as to ensure the clinical efficacy of this Chinese herbal drug.Chemical and pharmacological investigations on Flos Lonicerae resulted in discovering several kinds of bioactive components, i.e. chlorogenic acid and its analogues, flavonoids, iridoid glucosides and triterpenoid saponins [3]. Previously, chlorogenic acid has been used as the chemical marker for the quality evaluation of Flos Lonicerae,owing to its antipyretic and antibiotic property as well as its high content in the herb. But this compound is not a characteristic component of Flos Lonicerae, as it has also been used as the chemical marker for other Chinese herbal drugs such as Flos Chrysanthemi and so on[4-5]. Moreover, chlorogenic acid alone could not be responsible for the overall pharmacological activities of Flos Lonicerae[6].On the other hand, many studies revealed that triterpenoidal saponins of Flos Lonicerae possess protection effects on hepatic injury caused by Acetaminophen, Cd, and CCl4, and conspicuous depressant effects on swelling of ear croton oil [7-11]. Therefore, saponins should also be considered as one of the markers for quality control of Flos Lonicerae. Consequently, determinations of all types of components such as chlorogenic acid, flavonoids, iridoid glucosides and triterpenoidal saponins in Flos Lonicerae could be a better strategy for the comprehensive quality evaluation of Flos Lonicerae.Recently an HPLC-ELSD method has been established in our laboratory for qualitative and quantitative determination of iridoid glucosides in Flos Lonicerae [12]. But no method was reported for the determination of triterpenoidal saponins in Flos Lonicera. As a series studies on the comprehensive evaluation of Flos Lonicera, we report here, for the first time, the development of an HPLC-ELSD method for simultaneous determination of seven triterpenoidal saponins in the Chinese herbal drug Flos Lonicerae, i.e.macranthoidin B (1), macranthoidin A (2), dipsacoside B (3), hederagenin-28-O-β-D-glucopyranosyl(6→1)-O-β-D- glucopyranosyl ester (4), macranthoside B (5), macranthoside A (6), and hederagenin-3-O-α-L-arabinopyranosyl(2→1)-O-α-L-rhamnopyranoside (7) (Fig. 1).2. Experimental2.1. Samples, chemicals and reagentsFive samples of Lonicera species,L. japonica from Mi county, HeNan province (LJ1999-07), L. hypoglauca from Jiujang county, JiangXi province (LH2001-06), L. similes from Fei county, ShanDong province (LS2001-07), L. confuse from Xupu county, HuNan province (LC2001-07), and L. macranthoides from Longhu county, HuNan province (LM2000-06) respectively, were collected in China. All samples were authenticated by Dr. Ping Li, professor of department of Pharmacognosy, China Pharmaceutical University, Nanjing, China. The voucher specimens were deposited in the department of Pharmacognosy, China Pharmaceutical University, Nanjing, China. Seven saponin reference compounds: macranthoidin B (1), macranthoidin A (2), dipsacoside B (3), hederagenin-28-O-β-D-glucopyranosyl(6→1)-O-β-D- glucopyranosyl ester (4), macranthoside B (5), macranthoside A (6), and hederagenin-3-O-α-L-arabinopyranosyl(2→1)-O-α-L-rhamnopyranoside (7) were isolated previously from the dried buds of L. confusa by repeated silica gel, sephadex LH-20 and Rp-18 silica gel column chromatography, their structures were elucidated by comparison of their spectral data (UV, IR, MS, 1H- NMR and 13C-NMR) with references [13-15]. The purity of these saponins were determined to be more than 98% by normalization of the peak areas detected by HPLC with ELSD, and showed very stable in methanol solution.HPLC-grade acetonitrile from Merck (Darmstadt, Germany), the deionized water from Robust (Guangzhou, China), were purchased. The other solvents, purchased from Nanjing Chemical Factory (Nanjing, China) were of analytical grade.2.2. Apparatus and chromatographic conditionsAglient1100 series HPLC apparatus was used. Chromatography was carried out on an Aglient Zorbax SB-C18 column(250 4.6mm, 5.0µm)at a column temperature of 25℃.A Rheodyne 7125i sampling valve (Cotati, USA) equipped with a sample loop of 20µl was used for sample injection. The analog signal from Alltech ELSD 2000 (Alltech, Deerfield, IL, USA)was transmitted to a HP Chemstation for processing through an Agilent 35900E (Agilent Technologies, USA).The optimum resolution was obtained by using a linear gradient elution. The mobile phase was composed of acetonitrile(A) and water(B) which acidified with 0.5% acetic acid. The elution was operated from keeping 29%A for 10min, then gradually to 54%B from 10 to 25 min in linear gradient, and back to the isocratic elution of 54%B from 25 to 30 min.The drift tube temperature for ELSD was set at 106℃and the nitrogen flow-rate was of 2.6 l/min. The chromatographic peaks were identified by comparing their retention time with that of each reference compound tried under the same chromatographic conditions with a series of mobile phases. In addition, spiking samples with the reference compounds further confirmed the identities of the peaks.2.3. Calibration curvesMethanol stock solutions containing seven analytes were prepared and diluted to appropriate concentration for the construction of calibration curves. Six concentrationof the seven analytes’ solution were injected in triplicate, and then the calibration curves were constructed by plotting the peak areas versus the concentration of each analyte. The results were demonstrated in Table1.2.4. Limits of detection and quantificationMethanol stock solution containing seven reference compounds were diluted to a series of appropriate concentrations with methanol, and an aliquot of the diluted solutions were injected into HPLC for analysis.The limits of detection (LOD) and quantification (LOQ) under the present chromatographic conditions were determined at a signal-to-noise ratio (S/N) of 3 and 10, respectively. LOD and LOQ for each compound were shown in Table1.2.5. Precision and accuracyIntra- and inter-day variations were chosen to determine the precision of the developed assay. Approximate 2.0g of the pulverized samples of L. macranthoides were weighted, extracted and analyzed as described in 2.6 Sample preparation section. For intra-day variability test, the samples were analyzed in triplicate for three times within one day, while for inter-day variability test, the samples were examined in triplicate for consecutive three days. Variations were expressed by the relative standard deviations. The results were given in Table 2.Recovery test was used to evaluate the accuracy of this method. Accurate amounts of seven saponins were added to approximate 1.0g of L. macranthoides,and then extracted and analyzed as described in 2.6 Sample preparation section. The average recoveries were counted by the formula: recovery (%) = (amount found –original amount)/ amount spiked ×100%, and RSD (%) = (SD/mean) ×100%. The results were given in Table 3.2.6. Sample preparationSamples of Flos Lonicerae were dried at 50℃until constant weight. Approximate 2.0g of the pulverized samples, accurately weighed, was extracted with 60% ethanol in a flask for 4h. The ethanol was evaporated to dryness with a rotary evaporator. Residue was dissolved in water, followed by defatting with 60ml of petroleum ether for 2 times, and then the water solution was evaporated, residue was dissolved with methanol into a 25ml flask. One ml of the methanol solution was drawn and transferred to a 5ml flask, diluted to the mark with methanol. The resultant solution was at last filtrated through a 0.45µm syringe filter (Type Millex-HA, Millipore, USA) and 20µl of the filtrate was injected to HPLC system. The contents of the analytes were determined from the corresponding calibration curves.3. Results and discussionsThe temperature of drift tube and the gas flow-rate are two most important adjustable parameters for ELSD, they play a prominent role to an analyte response. In ourprevious work [12], the temperature of drift tube was optimized at 90°C for the determination of iridoids. As the polarity of saponins are higher than that of iridoids, more water was used in the mobile phase for the separation of saponins, therefore the temperature for saponins determination was optimized systematically from 95°C to 110°C, the flow-rate from 2.2 to 3.0 l/min. Dipsacoside B was selected as the testing saponin for optimizing ELSD conditions, as it was contained in all samples. Eventually, the drift tube temperature of 106℃and a gas flow of 2.6 l/min were optimized to detect the analytes. And these two exact experimental parameters should be strictly controlled in the analytical procedure [16].All calibration curves showed good linear regression (r2 0.9922) within test ranges. Validation studies of this method proved that this assay has good reproducibility. As shown in Table 2, the overall intra- and inter-day variations are less than 6% for all seven analytes. As demonstrated in Table 3, the developed analytical method has good accuracy with the overall recovery of high than 96% for the analytes concerned. The limit of detection (S/N=3) and the limit of quantification (S/N=10) are less than 0.26μg and 0.88μg respectively (Table1), indicating that this HPLC-ELSD method is precise, accurate and se nsitive enough for the quantitative evaluation of major non- chromaphoric saponins in Flos Lonicerae.It has been reported that there are two major types of saponins in Flos Lonicerae, i.e. saponins with hederagenin as aglycone and saponins with oleanolic acid as the aglycone [17]. But hederagenin type saponins of the herb were reported to have distinct activities of liver protection and anti-inflammatory [7-11]. So we adoptedseven hederagenin type saponins as representative markers to establish a quality control method.The newly established HPLC-ELSD method was applied to analyze seven analytes in five plant sources of Flos Lonicerae, i.e. L. japonica,L. hypoglauca,L. confusa,L. similes and L. macranthoides(Table 4). It was found that there were remarkable differences of seven saponins contents between different plant sources of Flos Lonicerae. All seven saponins analyzed could be detected in L. confusa and L. hypoglauca, while only dipsacoside B was detected in L. japonica. Among all seven saponins interested, only dipsacoside B was found in all five plant species of Flos Lonicerae analyzed, and this compound was determined as the major saponin with content of 53.7 mg/g in L. hypoglauca. On the other hand, macranthoidin B was found to be the major saponin with the content higher than 41.0mg/g in L. macranthoides,L. confusa, and L. similis, while the contents of other analytes were much lower.In our previous study [12], overall HPLC profiles of iridoid glucosides was used to qualitatively and quantitatively distinguish different origins of Flos Lonicerae. As shown in Fig.2, the chromatogram profiles of L. confusa, L. japonica and L. similes seem to be similar, resulting in the difficulty of clarifying the origins of Flos Lonicerae solely by HPLC profiles of saponins, in addition to the clear difference of the HPLC profiles of saponins from L. macranthoides and L. hypoglauca.Therefore, in addition to the conventional morphological and histological identification methods, the contents and the HPLC profiles of saponins and iridoids could also be used as accessory chemical evidence toclarify the botanical origin and comprehensive quality evaluation of Flos Lonicerae.4. ConclusionsThis is the first report on validation of an analytical method for qualification and quantification of saponins in Flos Lonicerae. This newly established HPLC-ELSD method can be used to simultaneously quantify seven saponins, i.e. macranthoidin B, macranthoidin A, dipsacoside B, hederagenin-28-O-β-D-glucopyranosyl(6→1)-O-β-D- glucopyranosyl ester, macranthoside B, macranthoside A, and hederagenin-3-O-α-L-arabinopyranosyl(2→1)-O-α-L-rhamnopyranoside in Flos Lonicerae. Together with the HPLC profiles of iridoids, the HPLC-ELSD profiles of saponins could also be used as an accessory chemical evidence to clarify the botanical origin and comprehensive quality evaluation of Flos Lonicerae.AcknowledgementsThis project is financially supported by Fund for Distinguished Chinese Young Scholars of the National Science Foundation of China (30325046) and the National High Tech Program(2003AA2Z2010).[1]Ministry of Public Health of the People’s Republic of China, Pharmacopoeia ofthe People’s Republic of China, V ol.1, 2000, p. 177.[2]W. Shi, R.B. Shi, Y.R. Lu, Chin. Pharm. J., 34(1999) 724.[3]J.B. Xing, P. Li, D.L. Wen, Chin. Med. Mater., 26(2001) 457.[4]Y.Q. Zhang, L.C. Xu, L.P. Wang, J. Chin. Med. Mater., 21(1996) 204.[5] D. Zhang, Z.W. Li, Y. Jiang, J. Pharm. Anal., 16(1996) 83.[6]T.Z. Wang, Y.M. Li, Huaxiyaoxue Zazhi, 15(2000) 292.[7]J.ZH. Shi, G.T. Liu. Acta Pharm. Sin., 30(1995) 311.[8]Y. P. Liu, J. Liu, X.SH. Jia, et al. Acta Pharmacol. Sin., 13 (1992) 209.[9]Y. P. Liu, J. Liu, X.SH. Jia, et al. Acta Pharmacol. Sin., 13 (1992) 213.[10]J.ZH. Shi, L. Wan, X.F. Chen.ZhongYao YaoLi Yu LinChuang, 6 (1990) 33.[11]J. Liu, L. Xia, X.F. Chen. Acta Pharmacol. Sin., 9 (1988) 395[12]H.J. Li, P. Li, W.C. Ye, J. Chromatogr. A 1008(2003) 167-72.[13]Q. Mao, D. Cao, X.SH. Jia. Acta Pharm. Sin., 28(1993) 273.[14]H. Kizu, S. Hirabayashi, M. Suzuki, et al. Chem. Pharm. Bull., 33(1985) 3473.[15]S. Saito, S. Sumita, N. Tamura, et al. Chem Pharm Bull., 38(1990) 411.[16]Alltech ELSD 2000 Operating Manual, Alltech, 2001, p. 16. In Chinese.[17]J.B. Xing, P. Li, Chin. Med. Mater., 22(1999) 366.Fig. 1 Chemical structures of seven saponins from Lonicera confusa macranthoidin B (1), macranthoidin A (2), dipsacoside B (3), hederagenin-28-O-β-D-glucopyranosyl(6→1)-O-β-D- glucopyranosyl ester (4), macranthoside B (5), macranthoside A (6), and hederagenin-3-O-α-L-arabinopyranosyl(2→1)-O-α-L-rhamnopyranoside (7)Fig. 2Representative HPLC chromatograms of mixed standards and methanol extracts of Flos Lonicerae.Column: Agilent Zorbax SB-C18 column(250 4.6mm, 5.0µm), temperature of 25℃; Detector: ELSD, drift tube temperature 106℃, nitrogen flow-rate 2.6 l/min.A: Mixed standards, B: L. confusa, C: L. japonica, D: L. macranthoides, E: L. hypoglauca, F: L. similes.Table 1 Calibration curves for seven saponinsAnalytes Calibration curve ar2Test range(μg)LOD(μg)LOQ(μg)1 y=6711.9x-377.6 0.9940 0.56–22.01 0.26 0.882 y=7812.6x-411.9 0.9922 0.54–21.63 0.26 0.843 y=6798.5x-299.0 0.9958 0.46–18.42 0.22 0.724 y=12805x-487.9 0.9961 0.38–15.66 0.10 0.345 y=4143.8x-88.62 0.9989 0.42–16.82 0.18 0.246 y=3946.8x-94.4 0.9977 0.40–16.02 0.16 0.207 y=4287.8x-95.2 0.9982 0.42–16.46 0.12 0.22a y: Peak area; x: concentration (mg/ml)Table 2 Reproducibility of the assayAnalyteIntra-day variability Inter-day variability Content (mg/g) Mean RSD (%) Content (mg/g) Mean RSD (%)1 46.1646.2846.2246.22 0.1346.2245.3647.4226.33 2.232 5.385.385.165.31 2.405.285.345.045.22 3.043 4.374.304.184.28 2.244.284.464.024.255.204 nd1)-- -- nd -- --5 1.761.801.821.79 1.701.801.681.841.77 4.706 1.281.241.221.252.451.241.341.201.26 5.727 tr2)-- -- tr -- -- 1): not detected; 2): trace. RSD (%) = (SD/Mean) ×100%Table 3 Recovery of the seven analytesAnalyteOriginal(mg) Spiked(mg)Found(mg)Recovery(%)Mean(%)RSD(%)1 23.0823.1423.1119.7122.8628.1042.7346.1351.0199.7100.699.399.8 0.722.692.672.582.082.913.164.735.515.7698.197.6100.698.8 1.632.172.152.091.732.182.623.884.404.6598.8103.297.799.9 2.94nd1)1.011.050.980.981.101.0297.0104.8104.1102.0 4.250.880.900.910.700.871.081.561.752.0197.197.7101.898.9 2.660.640.620.610.450.610.751.081.211.3397.796.796.096.8 0.97tr2)1.021.101.081.031.111.07100.9102.799.1100.9 1.81): not detected; 2): trace.a Recovery (%) = (Amount found –Original amount)/ Amount spiked ×100%, RSD (%) = (SD/Mean) ×100%Table 4 Contents of seven saponins in Lonicera spp.Content (mg/g)1 2 3 4 5 6 7 L. confusa45.65±0.32 5.13±0.08 4.45±0.11tr1) 2.04±0.04tr 1.81±0.03 L. japonica nd2)nd 3.44±0.09nd nd nd nd L. macranthoides46.22±0.06 5.31±0.13 4.28±0.10 tr 1.79±0.03 1.25±0.03 tr L. hypoglauca11.17±0.07 nq3)53.78±1.18nd 1.72±0.02 2.23±0.06 2.52±0.04 L. similes41.22±0.25 4.57±0.07 3.79±0.09nd 1.75±0.02tr nd 1): trace; 2): not detected.. 3) not quantified owing to the suspicious purity of the peak.。
脑卒中患者血清VILIP-1、PRDX1、Pannexin1表达水平及其与预后的关系
脑卒中患者血清VILIP-1、PRDX1、Pannexin1表达水平及其与预后的关系郝井志1,王瑞2,刘晓琳2延安大学咸阳医院脑血管病研究所1、检验科2,陕西咸阳721000【摘要】目的探讨脑卒中患者血清视锥蛋白样蛋白-1(VILIP -1)、过氧化还原蛋白1(PRDX1)、泛连接蛋白1(Pannexin1)的表达水平对预后的影响。
方法选取2020年1月至2022年3月延安大学咸阳医院脑血管病研究所诊治的110例脑卒中患者作为观察组,并选择同期我院120例身体健康的体检者作为对照组,比较观察组与对照组,观察组不同病情、不同预后患者的血清VILIP -1、PRDX1、Pannexin1水平,并采用多因素Logistic 回归分析影响脑卒中患者预后的危险因素。
结果观察组患者的VILIP -1、PRDX1、Pannexin1水平分别为(9.17±1.18)ng/mL 、(9.30±1.83)ng/mL 、(5.37±0.80)mg/mL ,明显高于对照组的(3.10±0.60)ng/mL 、(3.66±0.78)ng/mL 、(2.02±0.61)mg/mL ,差异均有统计学意义(P <0.05);随着脑卒中患者病情的严重程度加重,血清VILIP -1、PRDX1、Pannexin1表达水平均逐渐升高,其中重度组明显高于中度和轻度组,中度组明显高于轻度组,差异均有统计学意义(P <0.05);预后良好组患者的VILIP -1、PRDX1、Pannexin1水平分别为(4.69±0.81)ng/mL 、(7.46±1.68)ng/mL 、(4.95±1.13)mg/mL ,明显低于预后不良组的(7.98±1.25)ng/mL 、(12.01±1.93)ng/mL 、(6.14±1.29)mg/mL ,差异均有统计学意义(P <0.05);预后良好组患者的高血压、糖尿病、冠心病、高同型半胱氨酸、高脂血症、吸烟、酗酒的发生率明显低于预后不良组,差异均有统计学意义(P <0.05);经多因素Logistic 回归性分析结果显示,血清VILIP -1、PRDX1、Pannexin1均是影响脑卒中患者预后的危险因素(P <0.05)。
系统性红斑狼疮患者补体C3、C4水平变化的临床意义
系统性红斑狼疮患者补体C3、C4水平变化的临床意义李文兴;王一丁;石楠【摘要】目的:观察系统性红斑狼疮(Systemic lupus erythematosus,SLE)患者补体C3、C4水平变化并探讨其临床意义。
方法:选取我院2015年1月—2017年4月收治的122例SLE患者以及同期80名健康体检者,分别纳入患者组、对照组进行前瞻性分析。
按照SLE患者系统性红斑狼疮疾病活动性指数-2000(SLEDAI-2000)将患者分为轻度活动组(5~9分)、中度活动组(10~14分)、重度活动组(>14分)。
比较患者组、对照组以及患者不同亚组SLE患者补体C3、C4以及白蛋白(ALB)、高密度脂蛋白胆固醇(HDL-C)等指标变化,运用Pearson相关性分析,计算补体C3、C4与各类实验室指标及SLEDAI-2000评分的相关性。
结果:患者组C3、C4、ALB、HDL-C、LDL-C、IgA、IgM低于对照组,其IgG高于对照组,差异有统计学意义(P<0.05)。
随着患者病情活动度上升,其C3、C4、ALB、HDL-C、LDL-C、IgA、IgM逐渐下降,IgG逐渐上升,差异有统计学意义(P<0.05)。
C3、C4与ALB、HDL-C、LDL-C、IgA、IgM均呈正相关,与IgG均呈负相关,且C3与SLEDAI-2000呈负相关(P<0.05)。
结论:SLE患者补体C3、C4水平的下降与病情进展与病情活动度的上升有着密切关联,C3在反映SLE病情活动度方面的价值更为理想。
【期刊名称】《现代仪器与医疗》【年(卷),期】2018(024)001【总页数】3页(P67-69)【关键词】系统性红斑狼疮;补体C3;补体C4;疾病活动度【作者】李文兴;王一丁;石楠【作者单位】[1]四川省遂宁市中医院检验科,四川遂宁629000;;[1]四川省遂宁市中医院检验科,四川遂宁629000;;[1]四川省遂宁市中医院检验科,四川遂宁629000;【正文语种】中文【中图分类】R446系统性红斑狼疮(Systemic lupus erythematosus,SLE)是一种与激素、环境、遗传等多种因素有关的自身免疫系统疾病,患者主要病理生理改变包括淋巴细胞异常活化、补体系统过度激活、免疫复合物清除障碍、自身抗体大量产生、免疫调节紊乱等[1-2]。
水牛发情周期生殖激素变化规律及唾液结晶的分析
中国畜牧兽医2019,46(4):1101-1107China Animal Husbandry&Veterinary Medicine水牛发情周期生殖激素变化规律及唾液结晶的分析贾银海S李芳芳蒋世强3,李铭S徐文文S王国利S潘能庆3,杨秀荣",蒋和生"(1广西大学动物科技学院,南宁530004%.广西壮族自治区畜禽品种改良站,南宁530021;3.广西巴弗罗牧业投资有限公司,南宁530003)摘要:试验对水牛发情周期血清和唾液中雌二醇(E2)和孕酮(巳)的浓度变化规律、水牛唾液结晶与卵泡发育变化分别进行了分析研究,为进一步探讨水牛发情规律、指导生产提供依据。
采用酶联免疫分析法(ELISA)测定发情母水牛血清和唾液中E2和P4的浓度变化,并对血清和唾液的激素变化规律进行相关性分析。
结果表明,水牛血清和唾液中的E2和P4呈波动性变化。
发情前期,唾液中P4浓度一直维持在6.50〜7.10ng/mL,发情第13天达到1109ng/mL,随后快速下降。
唾液中E?浓度在发情第3〜5天出现一个峰值17853pg/mL,在第14〜17天唾液中E2浓度显著升高,出现第二个峰值17910pg/mL&母水牛唾液中E?和P°浓度的变化趋势与其在血清中的变化趋势基本一致,均呈显著相关(P V0.05);唾液中E2与巳浓度呈极显著相关(P V0.01)水牛发情当天唾液结晶呈现明显的蕨类作物形状且分维值显著低于其他时间点(P V0.05)水牛发情周期唾液结晶图形的变化与卵巢卵泡发育基本同步,可作为监测水牛发情及预测排卵的可靠指标之一&关键词:水牛;生殖激素;唾液结晶中图分类号:S814.1文献标识码:ADoi:10.16431/ki1671-7236.201904017The Variations and Correlation Analysis of Saliva Reproduction Hormones andCrystallization Patterns During Estrus Cycle in BuffaloesJIA Yinhai1,LI Fangfang2,JIANG Shiqiang3,LI Ming2,XU Wenwen1,WANG Guolf,PAN Nengqing3!YANG Xiurong1"!JIANG Hesheng1"(1.College of Animal Science and Technology,Guangxi Univer-Uy,Nanning530004,China;2.Guangxi Work Station of live-lock&Poultry Breed Improvement,Nanning530021,China;3.Guangxi Buffalo Husbandry Inee-tment Co.,Ltd.,Nanning530003,China)Abstract:The aim of the experiment was to explore the buffalo estrus and provide theoretical references for bu f alo production by studying the change laws of estradiol(E2)andprogesterone (P4)concentrationsduringestruscycleofsalivaryandserum investigatingthesalivaryferning and the development of ovaries in buffalo.The concentrations of E2and P4were determined by the enzymelinkedimmunosorbentassay(ELISA)inestruscycleandthecorrelationbetweentheser-umandsalivahormoneswereanalyzed$TheresultsshowthattheconcentrationsofE2andP4var-led fluctuantly.The concentration of saliva P4was maintained from6.50to7.10ng/mL at the be-ginningofestrus!0ndre0ched11.09ng/mL0t13dofestrusthenfe l f0st.Theconcentr0tionof收稿日期:2018-09-07基金项目:广西水产畜牧科技推广应用项目(桂渔牧科201633033^桂渔牧科201528001、桂渔牧科201528043);南宁市科学研究与技术幵发计划项目(201721342);南宁市青秀区科学研究与技术幵发计划项目(2017039)作者简介:贾银海(1977-),男,山西晋中人,博士,研究方向:动物遗传育种,E-mail:yinhail8@"通信作者:蒋和生(1962-),男,广西桂林人,博士,研究方向:动物遗传育种,E-mail:hsjiang@杨秀荣(1979-),女,广西桂林人,博士,研究方向:动物遗传育种,E-mail:xiurongyang09@1102中国畜牧兽医46saliva E2had two peaks,respectively at3-5d(178.53pg/mL)and1417d(179.10pg/mL)of estrus.The change trends of E2and P4levels in salivary and serum had the same change trends, the concentrations of salivary P4and E2had significant correlations with that in serum(P V0.05),while the salivary E2concentration also had a extremely significant correlation with thesalivaryP4concentration(P V0.01).Salivashowedatypicalfern-likecrysta l izationpa t ernsat 0dofestrus!withsignificantlylowerfractaldimensionvaluescomparedwiththeotherdaysofes-trus(P V0.05).Theresultswerealsoshowedthebasicsynchronizationbetweensalivacrysta l i-zationandovarianfo l icle.Inconclusionsalivacrysta l izationcouldbeusedasareliableindexfor monitoringestrusandpredictingovulationinbu f alo.Key words:buffalo;reproduction hormones;salivary crystallization水牛适应性强,肉和奶都具有较高的经济价值其与其他牛科动物相比繁殖率相对较低,发情外部症状和发情规律不明显,在印度有18%〜40%的水牛表现为发情不明显或者不育⑵。
89新生儿败血症血清降钙素原的动态改变
第3卷第3期2001年6月 中国当代儿科杂志Chin J Contemp PediatrVol.3No.3J une2001[收稿日期] 2000-09-23; [修回日期] 2001-02-15 [作者简介] 刘雪梅(1946-),女,大学,主任医师,科主任。
・论著・新生儿败血症血清降钙素原的动态改变刘雪梅,余健,罗莉漫(广州军区武汉总医院儿科,湖北3”武汉 430070) [摘 要] 目的 探讨新生儿败血症患儿血中降钙素原(procalcitonin PCT)的改变。
方法 以放免方法检测24例新生儿败血症患儿血中PCT的改变,同时检测20例缺血缺氧性脑病(HIE)以及16例正常足月儿作为正常对照。
结果 新生儿败血症患儿在急性期PCT较正常对照组明显升高[(112.23±10.13)μg/L vs(8.65±2.14)μg/L],(P<0.01);经抗生素治疗1周后降至正常水平(9.15±3.19)μg/L vs(8.63±2.96)μg/L,(P>0.05);而HIE组患儿PCT与正常对照组比较无明显的差别。
结论 新生儿败血症患儿在急性期血中PCT明显增高,对败血症的早期诊断有一定的价值。
[关 键 词] 降钙素原;败血症;新生儿[中图分类号] R72213+1 [文献标识码] A [文章编号] 1008-8830(2001)03-0221-03Dynamic V ariations of Serum Procalcitonin Levelsin N eonates with SepsisL IU Xue2Mei,YU Jian,LUO Li2ManDepart ment of Pediat rics,General Hospital of Guangz hou Com m and,W uhan430070,China Abstract: Objective To study the changes of serum procalcitonin(PCT)in neonates with sepsis.Methods Serum PCT was determined using an immunoradiometric assay in20newborn infants with neonatal se psis,24neonates with hypoxic2ischemic encephalopathy(HIE)and16healthy newborn controls.R esults Increased levels of serum PCT were found in neonates with se psis compared with the control group[(112.23±10.13)μg/L vs(8.65±2.14)μg/L], (P<0.01).After1week of treatment with appropriate antibiotics,PCT levels returned to normal.There was no difference between HIE neonates and the control group.Conclusions Elevated serum PCT levels are noted in neonatal sepsis.PCT might be of value in the diagnosis of neonatal sepsis. K ey w ords: Procalcitonin;Sepsis;Neonate 近期研究表明成人败血症时血中降钙素原(procalcitonin PCT)含量升高与病情的严重性密切相关,同时研究也发现,接受甲状腺切除的患者尽管血中PCT增高明显,但与血液中的降钙素的改变并无明显的相关关系[1]。
注射用硝普钠联合托拉塞米注射液与硝酸甘油注射液联合呋塞米注射
•疗效比较研究•注射用硝普钠联合托拉塞米注射液与硝酸甘油注射液联合呋塞米注射液治疗老年慢性心力衰竭临床疗效的对比研究佟刚,王娉娉,周长宇【摘要】目的比较注射用靖普纳联合托拉塞米注射液与靖酸甘油注射液联合吹塞米注射液治疗老年慢性心力衰竭的临床疗效。
方法选取2015年3月一2016年3月辽阳市中心医院收治的老年慢性心力衰竭患者124例,采用随机数字表法分为对照组和试验组,每组62例。
在常规治疗基础上,对照组患者给予硝酸甘油注射液联合吱塞米注射液治疗,试验组患者给予注射用硝普钠联合托拉塞米注射液治疗;两组患者均连续治疗5 d。
比较两组患者临床疗效,治疗前后收缩压、舒张压、血钾及血清心型脂肪酸结合蛋白(H-FABP)、可溶性ST2蛋白(s S T2)水平,并观察两组患者治疗期间不良反应发生情况。
结果试验组患者临床疗效优于对照组(尸<0.05)。
治疗前两组患者收缩压、舒张压、血钾比较,差异无统计学意义(P >0.05);治疗后试验组患者收缩压、舒张压、血钾高于对照组(P <0.05)。
治疗前两组患者血清H-FABP、sST2水平比较,差异无统计学意义(尸>0.05);治疗后试验组患者血清H-FABP、sST2水平低于对照组(P <0.05)。
两组患者治疗期间均未出现严重不良反应。
结论注射用硝普钠联合托拉塞米注射液治疗老年慢性心力衰竭的临床疗效优于硝酸甘油注射液联合吱塞米注射液,可有效降低血清H-FABP、sST2水平,保护心肌细胞,对血压和血钾影响较小,且安全性较高。
【关键词】心力衰竭;注射用硝普钠;托拉塞米注射液;老年人;硝酸甘油注射液;吱塞米注射液;疗效比较研究【中图分类号】R 541. 6【文献标识码】 B D0I: 10. 3969/j.issn. 1008 -5971.2017. 07.015{冬刚,王i夸辞,周长宇.注射用靖普纳联合托拉塞米注射液与靖酸甘油注射液联合吹塞米注射液治疗老年慢性心力衰竭临床疗效的对比研究[J].实用心脑肺血管病杂志,2017, 25 (7):66-69. [www. ]TONG G, WANG P P, ZHOU C Y. Comparative study for clinical effect in treating elderly patients with chronic heartfailure between sodium nitroprusside for injection combined with torasemide injection and nitroglycerin injection combined with furosemide injection [J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2017,25 (7) :66-69.Comparative Study for Clinical Effect in Treating Elderly Patients with Chronic Heart Failure between Sodium Nitroprusside for Injection Combined with Torasemide Injection and Nitroglycerin Injection Combined with FurosemideInjection TONG Gang,WANG Ping - ping,ZHOU Chang - yuThe Central Hospital o f Liaoyang,Liaoyang111 000,China[Abstract】Objective To compare the clinical effect in treating elderly patients with chronic heart failure betweensodium nitroprusside for injection combined with torasemide injection and nitroglycerin injection combined with furosemide injection. Methods A total of 124 elderly patients with chronic heart failure were selected in the Central Hospital of Liaoyangfrom March 2015 to March 2016, and they were divided into control group and test group according to random number table,each of 62 cases. Based on conventional treatment, patients of control group received nitroglycerin injection combined with furosemide injection, while patients of test group received sodium nitroprusside for injection combined with torasemide injection;both groups continuously treated for 5 days. Clinical effect, systolic blood pressure, diastolic blood pressure, serum kalium,serum levels of H-FABP and sST2 before and after treatment were compared between the two groups, and incidence of adverse reactions was observed during the treatment. Results Clinical effect of test group was statistically significantly better than that ofcontrol group (P <0. 05) . No statistically significant differences of systolic blood pressure, diastolic blood pressure or serumkalium was found between the two groups before treatment ( P > 0. 05 ) , while systolic blood pressure, diastolic blood pressureand serum kalium of test group were statistically significantly higher than those of control group after treatment ( P < 0. 05 ) . No 111000辽宁省辽阳市中心医院statistically significant differences of serum level of H-FABP or sST2 was found between the two groups before treatment ( P > 0.05 ),while serum levels of H-FABP and sST2 of test group were statistically significantly lower than those of control group after treatment (P< 0.05 ). No one of the two group occurred any serious adverse reactions during the treatment. Conclusion Sodium nitroprusside for injection combined with torasemide injection has better clinical effect than nitroglycerin injection combined with furosemide injection in treating elderly patients with chronic heart failure, can reduce the serum levels of H-FABP and sST2, protect the myocardial cell, has little effect on blood pressure and blood potassiam, and is relatively safe.【Keywords】Heart failure; Sodium nitroprusside for injection;Torasemide injection;Aged ;Nitroglycerin injection;Furosemide injection;Comparative effectiveness research慢性心力衰竭是多种器质性心脏病的终末期表现,其发病机制较复杂,可由多种心肌损伤因素共同作用导致,具有病死率高、预后差等特点[1]。
Invitrogen TrueCut Cas9 Proteins 说明书
For Research Use Only. Not for use in diagnostic procedures.TrueCut ™ Cas9 ProteinsCatalog Nos.A36496, A36497, A36498, A36499, A50574, A50575, A50576, A50577WARNING! Read the Safety Data Sheets (SDSs) and follow the handling instructions. Wear appropriate protective eyewear, clothing, and gloves. Safety Data Sheets (SDSs) are available from thermofi/support .Product descriptionInvitrogen ™ TrueCut ™ Cas9 Proteins are used for genome editing applications with CRISPR technology. Cas9 protein forms a very stable ribonucleoprotein (RNP) complex with the guide RNA (gRNA) component of the CRISPR-Cas9 system. Incorporation of nuclear localization signals (NLS) aid its delivery to the nucleus, increasing the rate of genomic DNA cleavage. It is cleared rapidly, minimizing the chance for off-target cleavage when compared to plasmid systems (Liang et al ., 2015). The Cas9 nuclease hasbeen tested in a wide variety of suspension and adherent cell lines and has shown superior genomic cleavage efficiencies and cell survivability compared to plasmid-based CRISPR systems.Two types of TrueCut ™ Cas9 Proteins are available for selection, depending upon the requirements of your particular experiment:• TrueCut ™ Cas9 Protein v2 is a recombinant Streptococcus pyogenes Cas9 (wt) protein that is the preferred choice for most CRISPR genome editing procedures where the highest level of editing efficiency is required. • TrueCut ™ HiFi Cas9 Protein is an engineered high fidelity Cas9 protein which is ideal for experiments that are sensitive to off-target events, while still maintaining a high level of editing efficiency.Table 1.Contents and storagePub. No. MAN0017066Rev.D.0Storage and handling• Store TrueCut ™ Cas9 Protein v2 and TrueCut ™ HiFi Cas9 Protein at –20°C until required for use. • Maintain RNAse-free conditions by using RNAse-free reagents, tubes, and barrier pipette tips while setting up your experiments.Before you beginMaterials required but notprovided• TrueGuide™ Synthetic gRNAs (see /trueguide)orGeneArt™ Precision gRNA Synthesis Kit (Cat. No. A29377)• Lipofectamine™ CRISPRMAX™ Cas9 Transfection Kit (Cat. Nos. CMAX00001,CMAX00003, CMAX00008, CMAX00015, CMAX00030) (for most cell lines)orNeon™ Transfection System (Cat. Nos. MPK5000, MPK1025, MPK1096) (for highesttransfection efficiency in challenging cell types including suspension cell lines)• GeneArt™ Genomic Cleavage Detection Kit (Cat. No. A24372)• Opti-MEM™ I Reduced Serum Medium (Cat. No. 31985-062)• 1X TE buffer, pH 8.0 (Cat. No. AM9849) and nuclease-free water (Cat. No. AM9914G)Prepare working stock ofTrueGuide™ Synthetic gRNA If TrueGuide™ Synthetic gRNA is being used, resuspend the gRNA (sgRNA, crRNA, ortracrRNA) in1X TE buffer to prepare 100 μM (100 pmol/μL) stock solutions.Before opening, centrifuge each TrueGuide™ Synthetic gRNA tube at low speed (maximum1.RCF 4,000 × g) to collect the contents at the bottom of the tube, then remove the cap from thetube carefully.Using a pipette and sterile tips, add the required volume of 1X TE buffer to prepare 100 μM2.(100 pmol/μL) stock solutions.3.Vortex the tube to resuspend the oligos, briefly centrifuge to collect the contents at thebottom of the tube, then incubate at room temperature for 15–30 minutes to allow the gRNAoligos to dissolve.Vortex the tube again to ensure that all the contents of the tube are resuspended, then briefly4.centrifuge to collect the contents at the bottom of the tube.(Optional) Check the concentration of the resuspended oligos using the NanoDrop™5.Spectrophotometer (or equivalent) or a UV-base plate reader.6.(Optional) Aliquot the working stock into one or more tubes for storage.Use working stocks immediately or freeze at –20°C until needed for use.7.(Optional) Generate gRNA byin vitro transcription If using in vitro transcribed gRNA with TrueCut™ Cas9 Protein v2 or TrueCut™ HiFi Cas9Protein in CRISPR-Cas9-mediated genome editing, the GeneArt™ Precision gRNA SynthesisKit is recommended for preparation of the gRNA. For detailed instructions on how togenerate full length gRNA, see the GeneArt™ Precision gRNA Synthesis Kit User Guide (Pub.No. MAN0014538), at .Transfection guidelinesGeneral CRISPR/gRNAtransfection guidelines• The efficiency with which mammalian cells are transfected with gRNA varies accordingto cell type and the transfection reagent used. See Table 2 (page 3) for delivery reagentrecommendations.• For gene editing (including gene knockout) editing efficiency is highest with a 1:1 molarratio of gRNA to TrueCut™ Cas9 Protein v2 or TrueCut™ HiFi Cas9 Protein. In some celltypes such as iPSC and THP1, we have used up to 2 μg TrueCut™ Cas9 Protein v2 and400 ng gRNA per well in 24-well format.• For HDR knock-in editing, a 1.5:1 molar ratio of donor ssODN to gRNA or TrueCut™ Cas9Protein v2 or TrueCut™ HiFi Cas9 Protein is recommend for highest knock-in efficiency.The donor can be added directly to RNPs (a premixed gRNA-Cas9 protein). If using adsDNA donor, further optimization may be necessary to determine the appropriate donoramount, since the toxicity level is dependent on the length and format of the donor DNAand cell type.• The optimal cell density for transfection varies depending on cell size and growthcharacteristics. In general, use cells at 30–70% confluence on the day of transfectionwith lipid-mediated delivery, or 70–90% confluence for electroporation using the Neon™Transfection System.• After the optimal cell number and dosage of Cas9/gRNA and/or donor that providesmaximal gene editing efficiency is determined for a given cell type, do not varyconditions across experiments to ensure consistency.For an overview of the factors that influence transfection efficiency, see the “TransfectionBasics” chapter of the Gibco™ Cell Culture Basic Handbook, available at /cellculturebasics.• Use the TrueGuide™ Positive Controls (human AVVS1, CDK4, HPRT1, or mouse Rosa 26)and negative control gRNA (non-coding) to determine gRNA amount and transfectionconditions that give the optimal gene editing efficiency with highest cell viability. TheTrueGuide™ Positive and Negative sgRNA and crRNA Controls are available separatelyfrom Thermo Fisher Scientific. For more information, refer to /trueguide.• The cell number and other recommendations provided in the following proceduresare starting point guidelines based on the cell types we have tested. For multiplewells, prepare a master mix of components to minimize pipetting error, then dispense theappropriate volumes into each reaction well. When making a master mix for replicate wells,we recommend preparing extra volume to account for any pipetting variations.Recommended deliveryoptions• Choosing the right delivery reagent is critical for transfection and gene editing efficiency.See our recommendations in Table 2. For more information on transfection reagents, see/transfection.• For cell line specific transfection conditions using the Lipofectamine™ CRISPRMAX™Transfection Reagent or the Neon™ Transfection System, see the Appendix (page 13).• For best results, perform electroporation and transfection of cells using both TrueCut™Cas9 Proteins and TrueGuide™ Synthetic gRNA.HiFi Cas9 Protein.Table 2. Recommended delivery options for TrueCut™ Cas9 Protein v2 and TrueCut™Guidelines for verification of editing efficiencyVerification of gene editingefficiency• Before proceeding with downstream applications, verify the gene editing efficiency of thecontrol target and select the condition that shows the highest level of editing efficiency forfuture screening experiments.• To estimate the CRISPR-Cas9-mediated editing efficiency in a pooled cell population,use the GeneArt™ Genomic Cleavage Detection Kit (Cat. No. A24372), or performIon Torrent™ next generation sequencing or a Sanger sequencing-based analysis.• While the genomic cleavage detection (GCD) assay provides a rapid method forevaluating the efficiency of indel formation following an editing experiment, nextgeneration sequencing (NGS) of the amplicons from the edited population or Sangersequencing of amplicons cloned into plasmids give a more accurate estimate of thepercent editing efficiency and indel types for knockout and HDR knock-in editing.GeneArt™ Genomic CleavageDetection (GCD) Assay• After transfections, use the GeneArt™ Genomic Cleavage Detection Kit (Cat. No. A24372)to estimate the CRISPR-Cas9-mediated cleavage efficiency in a pooled cell population.• You can design and order target-specific primer sets for the GCD assay through ourTrueDesign Genome Editor, available at /crisprdesign.• To perform the GCD assay for the positive control, you need the primers listed in Table 3.We recommend using Invitrogen™ Custom DNA Value or Standard Oligos, available from/oligos, for target specific primer sets needed for the GCD assay.• You can set up the GCD assay in a 96-well plate format and analyze multiple gRNA-treated samples in parallel on a 2% E-Gel™ 48 agarose gel (48-well).• For more information and detailed protocols, see the GeneArt™ Genomic Cleavage DetectionKit User Guide (Pub. No. MAN0009849), available for download at /GCDManual.Table 3. Target sequences for the positive and negative control (non-targeting) TrueGuide™ Synthetic gRNA sequences.Guidelines for clone isolation and validationAfter you have determined the cleavage efficiency of the pooled cell population, isolate single cell clones for further validation and banking. You can isolate single cell clones from the selected pool using limiting dilution cloning (LDC) in 96-well plates or by single cell sorting using a flow cytometer.Limiting dilution cloning(LDC)• Based on the editing efficiency and estimated cell viability, you can estimate the number of single clones needed to obtain a desired knock-out (KO) clonal cell line. For example, if you desire a homozygous KO with mutations in both copies of a gene and the resulting GeneArt ™ cleavage detection efficiency was 50%, then the probability of having both alleles knocked out in any cell is 25% (0.5 × 0.5 = 0.25).If the probability of an indel leading to frame shift is 2/3, then the chance of having a homozygous KO is ~11% per cell [(0.5 × 0.5) × (0.66 × 0.66) = 0.11].• We recommend performing limiting dilution by targeting 0.8 cells/well, which requires you to resuspend the transfected cells (post-counting) at a density of8 cells/mL in complete growth medium, then transferring 100 µL of this to each well of a 96-well plate. If you plate at least ten 96-well plates in this manner and expect only 20% of cells tosurvive, then the probability of having homozygous KO clones in the 192 surviving cells will be 19–21 cells (192 × 11%).• Note that single cell clone survivability varies by cell type. Some cells that do not like to remain as single cells need to be plated at a low density to get well separated colonies, which will then have to be manually picked for further screening.Example LDC procedureusing 293FT cells1. Wash the transfected cells in each well of the 24-well plate with 500 µL of PBS. Carefully aspirate the PBS and discard.2. Add 500 µL of TrypLE ™ cell dissociation reagent to the cells and incubate for2–5 minutes at 37°C.3. Add 500 µL of complete growth medium to the cells to neutralize the dissociation reagent.Pipette the cells up and down several times to break up the cell aggregates. Make sure that the cells are well separated and are not clumped together. 4. Centrifuge the cells at 300 × g for 5 minutes to pellet.5. Aspirate the supernatant, resuspend the cells in an appropriate volume of pre-warmed(37°C) growth medium, then perform a cell count. 6. Dilute the cells to a density of 8 cells/mL of complete growth medium. Prepare a total ofSequence analysis• For next generation sequencing (NGS) based editing efficiency analysis, you canspecifically amplify the edited region and barcode amplicons by pooling all amplicons in a single tube and performing sequencing using various NGS platforms such as the Ion Torrent ™ Targeted Amplicon-seq Validation (TAV). For more information on NGS analysis, refer to Ion Torrent ™ targeted sequencing solutions at /ionapliseqsolutions .• For Sanger sequencing-based editing efficiency analysis, refer to our application note referenced at /sangercrispr .• Use the SeqScreener Gene Edit Confirmation App on Thermo Fisher ™ Connect todetermine the spectrum and frequency of targeted mutations (see Pub. No. MAN0019454 at . for details).50 mL of cell suspension at this cell density and transfer to a sterile reservoir.Note: You can also perform a serial dilution to get a better estimate of cell density.Using a multichannel pipettor, transfer 100 µL of the cell suspension into each well of 96-well7.tissue culture plates until the desired number of plates is seeded. Make sure to mix the cellsin between seeding the plates to avoid the formation of cell aggregates.Note: In general, we seed ten 96-well plates to achieve a large number of clones. Numberof plates to seed depends on the editing efficiency of pooled cell population and viability ofcells post single cell isolation.Incubate the plates in a 37°C, 5% CO2 incubator.8.Scan the plates for single cell colonies as soon as small aggregates of cells are visible under a9.4X microscope (usually after first week, depending on the growth rate of the cell line).Continue incubating the plates for an additional 2–3 weeks to expand the clonal populations10.for further analysis and characterization.Example single cell sortingprocedure in a 96-well plateusing flow cytometer Single cells can be sorted into a 96-well plate format using a flow cytometer with singlecell sorting capability. After sorting and expanding the single cell clones, analyze andcharacterize the clonal populations using suitable assays.1.Wash the transfected 293FT cells in each well of the 24-well plate with 500 µL of PBS.Carefully aspirate the PBS and discard.Add 500 µL of TrypLE™ cell dissociation reagent and incubate for 2–5 minutes at 37°C.2.Add 500 µL of complete growth medium to the cells to neutralize the dissociation reagent.3.Pipette the cells up and down several times to break up the cell aggregates. Make sure thatthe cells are well separated and are not clumped together.Centrifuge the cells at 300 × g for 5 minutes to pellet.4.5.Aspirate the supernatant, then wash the cell pellet once with 500 μL of PBS.Resuspend 1 × 106 cells in 1 mL of FACS buffer, then add propidium iodide (PI) to the cells at6.a final concentration of 1 µg/mL. Keep the resuspended cells on ice.Filter the cells using suitable filters before analyzing them on a flow cytometer with single7.cell sorting capability.Sort PI-negative cells into a 96-well plate containing 100 μL of complete growth medium. If8.desired, you can use 1X antibiotics with the complete growth medium.Incubate the plates in a 37°C, 5% CO2 incubator.9.Scan the plates for single cell colonies as soon as small aggregates of cells are visible under10.a 4X microscope. Colonies should be large enough to see as soon as 7–14 days (usually afterfirst week, depending on the growth rate of the cell line). You can perform image analysis toensure that the colonies are derived from single cells.11.After image analysis, continue incubating the plates for an additional 2–3 weeks to expandthe clonal populations for further analysis and characterization.Characterize edited clones You can analyze the single cell clones for purity and the desired genotype (homozygous orheterozygous allele) by various molecular biology methods such as genotyping PCR, qPCR,next generation sequencing, or western blotting.Supporting tools At Thermo Fisher Scientific, you can find a wide variety of tools to meet your gene editingand validation needs, including Invitrogen™ LentiArray CRISPR and Silencer™ Select RNAilibraries for screening, primers for targeted amplicon sequencing, antibody collection forknock-out validation, and ORF collections and GeneArt™ gene synthesis service for cDNAexpression clones that can be used for rescue experiment reagents.thermofisher .com/support | thermofisher .com/askaquestion thermofisher .comLimited product warrantyLife Technologies Corporation and/or its affiliate(s) warrant their products as set forth in the Life Technologies’ General Terms and Conditions of Sale found on Life Technologies’ website at /us/en/home/global/terms-and-conditions.html . If you have any questions, please contact Life Technologies at www /support .Manufacturer: Thermo Fisher Scientific Baltics UAB | V. A. Graiciuno 8 | LT-02241 Vilnius, LithuaniaThe information in this guide is subject to change without notice.DISCLAIMER: TO THE EXTENT ALLOWED BY LAW, LIFE TECHNOLOGIES AND/OR ITS AFFILIATE(S) WILL NOT BE LIABLE FOR SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, MULTIPLE OR CONSEQUENTIAL DAMAGES IN CONNECTION WITH OR ARISING FROM THIS DOCUMENT, INCLUDING YOUR USE OF IT.Revision history:Pub. No. MAN0017066Important Licensing Information: These products may be covered by one or more Limited Use Label Licenses. By use of these products, you accept the terms and conditions of all applicable Limited Use Label Licenses.©2021 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified .。
甲状腺功能减退症病例讨论ppt模板
一甲状腺激素合成及调节 二病例讨论
1中老年甲减 2妊娠甲减 3非甲状腺性疾病甲状腺激素异常综合征
一 甲状腺激素的合成及调节
• 成人每日需要新合成100g的甲状腺素(T4)以供 机体所需 合成这些T4每日最低需碘量为65g
• 理想碘平均摄入量:
青少年和成人150g/d 青春期前儿童120g/d 怀孕和哺乳期妇女200g/d
Body
L-T4
Age Weight TSH Dose
L-T4 TSH on
(kg)
(mcg/d) Mcg/kg therapy
Sick 72 58* 47 97* 1.67* 3.6
Healthy 71
67
71 144 2.15
3.0
* P<0.01
老年人甲状腺状态与累计死亡率(3.7±1.4年)
ATA建议:35岁以上妇女 每5年筛查一次,TSH 5-10 每年筛查 TSH>10 开始治疗
甲减替代治疗原则
1. 青、中年不伴T4禁忌证者: 起始50ug/d,每间隔一 个月左右上调25ug/d 或
<50岁病程短无心脏病者开始即可足量替代(1.6ug/ 公斤理想体重或0.8ug/lb/d)
2 TSH靶值0.5-2.5-3mU/l ,使FT4 水平略高 保持 T3正常 每4~6周测定T4及TSH
甲减治疗经验
Variations in L-T4 Replacement with Different Causes of Hypothyroidism
Gordon and Gordon,1999
甲减不同原因平均每日L-T4 剂量有统计学意义差别
P<0.001 for all comparisons
早孕期产前筛查标志物及D-二聚体水平预测母体子痫前期的诊断价值
• 720•浙江临床医学202丨年5月第23卷第5期•检测诊断•早孕期产前筛查标志物及D-二聚体水平预测母体子痫前期的诊断价值褚雪莲陈益明*顾琳媛陈怡洁谢真李倒瑶宁雯雯汪晓莹【摘要】目的 了解早孕期产前筛查标志物(PA PP-A、F re e P-h C G和N T)及母血清D-二聚体(D-D)水平预测母体后期发生子痫前期(P E)的诊断价值方法采用回顾性病例对照研究方法,随机抽取2014年丨丨月至2019年4月杭州市妇产科医院产科住院分娩的267例孕妇资料,其中,47例正常孕妇、126例妊娠期高血压(G H)、53例PE和41例重度子痫前期(S P E),采用受试者工作特征曲线(R O C)来评价 早孕期血清D-D水平对PE等妊娠期高血压疾病(H D P)的诊断价值结果G H、PE和SPE组的D-D水平分别为(266.85 ±40.77 ) n g/m l、( 293.61 ±49.74 ) ng/m l和(326.46±43.16) n g/m l,均高于对照组(219.37±42.04 ) n g/m l,差异有统计学意义(F=49.798,P<0.001 )。
G H、PE和SPE组PA PP-A、F re e p-h C G和N T水平均低于对照组,差异无统计学意义(P>0.05)。
D-D对G H、PE、SPE的AUC分别为0.781、0.859、0.961,当0—0的(:1«〇«'值分别为235.18|18/1111、287.21 叩/111丨、280.17叩/111丨时,对应的灵敏度和特异度分别为0.746、0.585、0.829和 0.681、1.000、0.957,结论早孕期孕妇血清D-D水平与G H、PE具有相关性和诊断价值,且有随着高血压病情进展,孕妇血清D-D水平 有逐渐增高的趋势。
不同HD P类型的灵敏度和特异度差异较大,以SPE的灵敏度和特异度最佳。
Serumparameterso...
Serum parameters of Adriatic sturgeon Acipenser naccarii(Pisces: Acipenseriformes):effects of temperature and stressE.Cataldi a,*,P.Di Marco a,A.Mandich b,S.Cataudella aa Dipartimento di Biologia,Uni6ersita`‘Tor Vergata’,Via della Ricerca Scientifica,00133Rome,Italyb Istituto di Anatomia Comparata,Uni6ersita`di Geno6a,Via Benedetto XV5,16132Geno6a,ItalyReceived24March1998;received in revised form17September1998;accepted18September1998AbstractData on the concentrations of some blood constituents of captive Adriatic sturgeon,Acipenser naccarii,a primitive bonyfish, are reported.Serum osmolality,Na+,K+,Cl−,Ca2+,cortisol,glucose and total protein concentrations were measured.The effects of anaesthesia,temperature,crowding and prolonged handling stress were tested on a group of124-year-old sturgeons sampled repeatedly.The anaesthetic dose of MS222(140mg l−1)induced significant osmolality elevation in the sturgeon.After exposure to colder temperature(17versus25°C),cortisol and Cl−concentrations significantly decreased.The cultured sturgeon did not seem susceptible to crowding and prolonged handling stress,since neither the serum cortisol and glucose levels nor the other blood parameters were affected by these stressors.Results are compared with the few available data on other chondrostean fish and with those on teleosts.©1998Elsevier Science Inc.All rights reserved.Keywords:Acipenser naccarii;Blood chemistry;Cortisol;Osmolality;Serum constituent;Stress;Sturgeon;Temperature1.IntroductionBlood parameters are increasingly used as indicators of the physiological or sublethal stress response infish to endogenous or exogenous changes.The possibility of evaluation depends on the availability of reference val-ues as close as possible to‘normal’values of the various blood components considered as reliable descriptors of healthyfish under natural conditions.Taking into account the long evolutionary history of bonyfishes and the many adaptations to different environments,no species can be used as a representa-tive model for allfish.This explains the rapidly expand-ing literature on the chemical properties offish blood. However,at present,few reports deal with the blood of primitivefish(e.g.the chondrosteans),as is evident from the extensive reviews of the subject offish blood [9].The Adriatic sturgeon,Acipenser naccarii,is a species endemic to the waters of North Italy and the countries bordering the eastern Adriatic.Little is known about the ecology and biology of this primitive bonyfish [3,11–14,16].It is generally considered a euryhaline species,because it is sometimes found in estuaries.Once abundant in all the riversflowing into the North Adri-atic Sea,its present distribution range has been greatly reduced by the impact of overfishing and habitat deteri-oration.Interest in this species was recently aroused by successful attempts at artificial reproduction[1],which suggest that Acipenser naccarii may be suitable forfish farming and restocking.Therefore it is important to provide reference values for an assessment of the status of this species in both natural and rearing conditions. In this initial study on the blood chemistry of captive Italian sturgeons,the concentrations of some compo-nents of the serum were measured and the variations resulting from temperature,anaesthesia,crowding and handling,which represent some conditions associated*Corresponding author.Fax:+3962026189;e-mail:*******************1095-6433/98/$-see front matter©1998Elsevier Science Inc.All rights reserved. PII S1095-6433(98)10134-4E.Cataldi et al./Comparati6e Biochemistry and Physiology,Part A121(1998)351–354 352with culture practices and sampling procedure,were recorded.2.Materials and methods2.1.Origin and maintenance offishAdriatic sturgeon juveniles,derived from artificial reproduction,were reared in the Laboratory of Experi-mental Ecology and Aquaculture of the University‘Tor Vergata’of Rome.Fish were maintained in square fiberglass tanks supplied with freshwater at25°C and at a density of8kg m−3.Sturgeon were fed on commer-cial dry pellets(Universal Mangimi).A group of124-year-oldfish,which had mean (9S.D.)weight and total length of2.391.2kg and 82.2913.4cm,respectively,were used and repeatedly sampled in different conditions,after allowing the spec-imens to recover for a minimum of15days[9].Fish were fasted for2days before sampling.2.2.Sampling conditionsIn thefirst trial,blood samples were rapidly collected by cardiac puncture from sturgeons serially netted and manually immobilized without anaesthesia.After15days,the recovered sturgeons were sampled after anaesthesia in140mg l−1buffered solution of tricaine methane sulphonate(MS222),which induced loss of body and opercular movements within4–8min after exposure.In the third trial,fish previously acclimated for1 month to17°C were sampled after anaesthesia as above.The sturgeons maintained at a low temperature (17°C)were then exposed to crowding stress by confi-nement to a tank for24h at a density of16kg m−3.In addition,the sturgeons were stressed by prolonged han-dling.Anaesthetizedfish were sampled as above.2.3.Variables examined and analytical methods Clotted blood was centrifuged at3000×g for10min and the analyses were performed immediately.Serum osmolality was determined by a cryoscopic method (One-ten Osmometer,Fiske).Na+,K+and Cl−con-centrations were measured using an electrolyte analyzer with ion-specific electrodes(SPOTCHEM SE-1510, Menarini).Glucose,calcium and total protein were determined using an autodry chemistry analyzer (SPOTCHEM SP-4410,Menarini).Cortisol concentration was measured using Coat-A-Co Cortisol(Kontron Analytical MDA312)and ra-dioimmunoassay software.The kits were supplied by Diagnostic Product Corporation.2.4.Data analysisRange values,means and standard deviations were determined for all the parameters examined.Differ-ences between groups as regards both serum compo-nent concentrations and Na:Cl ratio were analyzed by the Mann–Whitney U-test.Significance was accepted at P B0.01.The contribution of Na+and Cl−to total serum osmolality was obtained using the formula Osm NaCl= (Na++Cl−)×0.91[9].3.ResultsThe effects of anaesthesia,temperature,crowding and handling stress on mean value of the blood parameters are reported in Table1.In all the different sampling conditions tested,the individual plasma cortisol and glucose concentrations were found to be highly variable(as indicated by the range reported in Table1)and the increase in levels did not depend on the order in which thefish were taken from the tank.The values of these parameters,for example,in sturgeons maintained at25°C and serially sampled without anaesthesia were,progressively,45.5, 116.4,43.0,77.5,303.5,177.1,17.1,31.4,44.7,186.7, 142.3nmol l−1and1.7,1.8,2.3,1.9,3.9,3.8,1.1,1.6, 1.7,1.4,2.2mmol l−1,respectively.The values of the other parameters were more constant.The comparison between sturgeon maintained at 25°C sampled with and without anaesthesia showed that the anaesthetized sturgeon differed significantly only in its higher osmolality.The trend of Na+and Cl−concentrations was also towards higher levels,and in fact contributed to total osmolality about in the same percentage(Osm NaCl=237.0mOsm kg−1;83.4%) as non-anaesthetized sturgeon(Osm NaCl=230.6mOsm kg−1;88%).The Na:Cl ratios in anaesthetized and non-anaesthetized sturgeons,respectively1.22and1.24, were not significantly different.After acclimation to the temperature of17°C,the cortisol level and Cl−concentration decreased signifi-cantly.Na+and Cl−(Osm NaCl=220.8)contributed only79.6%to total serum osmolality,due to very low Cl−concentration.In fact,the Na:Cl ratio measured 1.46in this group.The other blood parameters were unaffected by low temperature acclimation. Crowding and prolonged handling did not seem to affect sturgeon blood chemistry.In fact,no significant increase in mean serum cortisol or glucose levels or in other components were detected.Nevertheless,the indi-vidual concentrations of all parameters resulted in a much broader range than the respective values mea-sured in unstressed sturgeon.E.Cataldi et al./Comparati6e Biochemistry and Physiology,Part A121(1998)351–354353 Table1Mean9S.D.and range(in parentheses)values of serum constituents of Adriatic sturgeon sampled at25°C with and without anaesthesia,and at 17°C with and without stressGroupAnaesthetized,Anaesthetized,Not anaethetized,Anaesthetized,not stressed,not stressed,not stressed,stressed,17°C(n=12)25°C(n=11)25°C(n=11)17°C(n=12)83.6945.52(62.2–153.9)32.0918.7b(13.2–81.4)Cortisol(nmol l−1)43.0943.8(2.7–172.1) 107.8988.0(17.1–303.5)2.390.9(1.3–4.0) 2.691.1(1.4–4.6)Glucose(mmol l−1) 2.190.9(1.1–3.9) 3.491.6(1.3–6.7)277.193.9(270.7–283.3)273.396.0a(266.0–286.2)279.596.8(269.6–291.0) 262.4.96.9(251.0–280.3)Osmolality(mOsm kg−1)143.595.2(136.0–154.0)144.193.7(137.0–148.0)Na+(mEq l−1)140.694.8(134.0–152.0)143.695.5(135.0–155.0)3.490.8(2.4–5.3) 3.290.5(2.7–4.5)K+(mEq l−1) 3.690.3(3.0–4.3) 3.190.3a(2.7–3.7)117.093.1(112.0–122.0)98.596.5b(88.0–107.0)Cl−(mEq l−1)112.993.5(107.0–120.0)104.393.7(98.0–111.0)2.390.3(1.7–2.8) 2.690.3(1.9–2.9) 2.490.3(1.8–2.9)2.390.1(2.1–2.6)Ca2+(mEq l−1)2.290.3(1.9–2.6) 2.390.3(1.9–2.8) 2.590.5(1.9–3.6) 2.590.6(1.9–3.6)T-protein(g dl−1)The four groups were compared using the Mann–Whitney U-test.a Significant difference,at P B0.01,between sturgeon sampled at25°C with and without anaesthesia.b Significant difference,at P B0.01,between sturgeon sampled at25°C and17°C and anaesthetized.4.DiscussionIn sturgeon[7],as well as in teleosts[9],the in-crease of serum cortisol level was considered a pri-mary indicator of stress response.The other para-meters were also liable to change in response to stress or environmental variations.The serum cortisol levels detected in sturgeon main-tained at17°C are consistent with the‘normal’values reported in Acipenser baeri,whereas the high levels found at25°C are consistent with those found under acute hypoxic stress in the same species[7]. Therefore the cortisol level detected at17°C might suggest a relatively‘unstressed’condition of captive Adriatic sturgeon at such temperatures,and all the parameters measured might also be considered as ‘normal’values.The glucose mean value is lower than resting levels detected in A.baeri[7].Total protein is in the range of values measured in the Russian stur-geon[15].However,osmolality and ion concentra-tions might be affected slightly by anaesthesia,as in sturgeons sampled at25°C.The effect of anaesthesia on salt and water balance was clearly demonstrated in teleosts[4].Nevertheless,the serum osmolality and ion concentrations measured in the low-temperature group are comparable to the values indicated for Acipenser transmontanus,a euryhaline sturgeon[10]. In A.naccarii Na+and Cl−contribute to over75% of total osmolality as in teleosts,whereas the Na:Cl ratio(1.46)may be considered exceptional,and is the same only in anguillids.In other teleosts it averages 1.1[9].To elucidate true resting levels of serum parameters of this primitive bonyfish,daily and seasonalfluctua-tions will have to be checked.Moreover,in eury-haline anadromous teleost species,and presumably in the Adriatic sturgeon,some parameters can be linked to physiological adjustments to migration.The higher cortisol value measured in sturgeon maintained at25°C may indicate that upper tempera-ture causes chronic stress,which also affects ion con-centration.The Adriatic sturgeon was successfully reared at constant high temperature conditions(239 2°C)which offered better growth performance if com-pared to sturgeon grown both at15–18°C and at fluctuating temperature regimes(10–30°C)[2].How-ever,in some teleosts,temperature preferences have been reported and they may depend on endogenous and environmental conditions[5,6].A.naccarii does not seem susceptible to crowding and handling stress.The mean values of cortisol,glu-cose and osmolality,in fact,were not altered;further-more,no apparent cumulative effects were observed. This could suggest the domesticated conditions of the hatchery-reared sturgeons,as it has been demon-strated in chinook salmon[8].However,the different individual susceptibility to stressors,as indicated by the broad range of values detected,may be an important consideration in the evaluation of certain situations. AcknowledgementsThis research was carried out within the‘Project for the Development of National Aquaculture,1993–1997’supported by a grant from Italian Ministry of Agriculture(L.201/91).E.Cataldi et al./Comparati6e Biochemistry and Physiology,Part A121(1998)351–354 354References[1]Arlati G,Bronzi P,Colombo L,Giovannini G.Induzione dellariproduzione dello storione italiano(Acipenser naccarii)allevato in cattivita`.Riv Ital Acquacolt1988;23:94–6.[2]Arlati G,Bronzi P.Sturgeon farming in Italy.In:GershanovichAD,Smith TIJ,editors.Proceedings of Second International Symposium on Sturgeons,6–11September1993,Moscow.Moscow:VNIRO,1995:321–32.[3]Cataldi E,Ciccotti E,Di Marco P,Di Santo O,Bronzi P,Cataudella S.Acclimation trials of juvenile Italian sturgeon to different salinities:morpho-physiological descriptors.J Fish Biol 1995;47:609–18.[4]Eddy FB.Effects of stress on osmotic and ionic regulation infish.In:Pickering AD,editor.Stress and Fish.New York: Academic Press,1981:209–245.[5]Elliot JM.Some aspects of thermal stress on freshwater teleosts.In:Pickering AD,editor.Stress and Fish.New York:Academic Press,1981:77–102.[6]Hazel JR.Thermal biology.In:Evans DH,editor.The Physiol-ogy of Fishes.London:CRC Press,1993:427–467.[7]Maxime V,Nonnotte G,Peyraud C,Williot P,Truchot JP.Circulatory and respiratory effects of an hypoxic stress in the Siberian sturgeon.Resp Physiol1995;100:203–12.[8]Mazur CF,Iwama GK.Effect of handling and stocking densityon hematocrit,plasma cortisol,and survival in wild and hatch-ery-reared chinnok salmon(Oncorhynchus tshawytscha).Aqua-culture1993;112:291–9.[9]McDonald DG,Milligan CL.Chemical properties of the blood.In:Hoar WS,Randall DJ,Farrell AP,editors.Fish Physiology, vol.XIIB.London:Academic Press,1992:56–133.[10]McEnroe A,Cech JJ.Osmoregulation in white sturgeon:lifehistory aspects.Am Fish Soc Symp1987;1:191–6.[11]Paccagnella B.Osservazioni sulla biologia degli storioni delBacino Padano.Arch Oceanogr Limnol1948;5:141–54. [12]Potts WT,Rudy PP.Aspects of osmotic and ionic regulation inthe sturgeon.J Exp Biol1972;56:703–15.[13]Rochard E,Castelnaud G,Lepage M.Sturgeons(Pisces:Acipenseridae):threats and prospects.J Fish Biol1991;37(Suppl.A):123–32.[14]Rossi R,Grandi G,Trisolini R,Franzoi P,Carrieri A,DezfuliBS,Vecchietti E.Osservazioni sulla biologia e la pesca dello storione cobice Acipenser naccarii Bonaparte nella parte termi-nale delfiume Po`.Atti Soc Ital Sci Nat Museo Civico Storia Nat Milano1992;132:121–42.[15]Skelukhin GK,Metallov GF,Geraskin PP.Effect of tempera-ture and salinity of Caspian sea water on juvenile Russian sturgeon,Acipenser guldenstadti.Voprosy Iktiologii1990;30: 296–304.[16]Tortonese E.Acipenser naccarii Bonaparte,1836.In:Holcik J,editor.The Freshwater Fishes of Europe.General Introduction to Fishes.Acipenseriformes,vol.I,part II.Wiesbaden:AULA-Verlag,1989:285–93.。
IgA_肾病患者肾组织、血清、尿液C4d水平与病情和疗效的关系
IgA 肾病患者肾组织、血清、尿液C 4d 水平与病情和疗效的关系王真硕1,李艳存2,李巧英31 北京积水潭医院检验科,北京100035;2 北京市大兴区中西医结合医院肾内科;3 北京市大兴区中西医结合医院急诊内科摘要:目的 探讨肾组织、血清、尿液中人补体片段4d (C 4d )水平对IgA 肾病(IgAN )患者病情、疗效及预后的评估价值。
方法 选取原发性IgAN 患者214例,采用经皮肾穿刺活检术取肾组织,免疫组化法检测C 4d 表达情况;采集患者血清和尿液,ELISA 法检测C 4d 水平。
比较肾组织、血清及尿液C 4d 不同表达水平患者的临床病理资料。
给予ACEI /ARB 药物联合免疫抑制剂治疗6~8个月后观察疗效,采用Spearman 相关分析法分析肾组织、血清、尿液C 4d 表达与治疗效果的相关性。
于随访截止日对患者进行肾功能CDK 分期,比较不同分期患者肾组织、血清、尿液C 4d 表达水平差异。
结果 肾组织C 4d 表达阳性76例、阴性138例,血清C 4d 水平为(1 270.27 ± 332.99)ng /mL ,尿液C 4d 水平为(297.53 ± 45.53)ng /mL 。
与肾组织C 4d 阴性患者比较,肾组织C 4d 阳性患者24 h 尿蛋白定量更高,血白蛋白更低(P 均<0.05);与血清C 4d 低水平患者比较,血清C 4d 高水平患者24 h 尿蛋白定量更高,血白蛋白更低(P 均<0.05);与尿液C 4d 低水平患者比较,尿液C 4d 高水平患者MAP 、24 h 尿蛋白定量、Scr 更高,eGFR 、血白蛋白更低(P 均<0.05),且病理分期更为严重。
治疗后214例患者完全缓解143例,部分缓解28例,无反应(无效+终末期肾病)43例。
相关性分析显示,肾组织、血清、尿液C 4d 水平升高与IgAN 患者的治疗效果呈负相关(r s 分别为-0.234、-0.270、-0.324,P 均<0.01),其中尿液C 4d 与治疗效果的相关性最强。
血清异常凝血酶原检测对原发性肝癌诊断的临床价值
血清异常凝血酶原检测对原发性肝癌诊断的临床价值袁丽仙 1),张洪涛 1),李 锐 2),陈昆锐 3),陈坤前 4),徐安书 5)(1)昆明医科大学附属曲靖医院核医学科;2)医务部;3)感染科;4)心脏血管外科;5)普外科,云南 曲靖 655000)[ 摘要 ] 目的 分析血清异常凝血酶原(protein induced by vitamin K absence or antagonist-Ⅱ,PIVKA-Ⅱ)对原发性肝癌诊断的临床价值及意义。
方法 选取昆明医科大学附属曲靖医院诊治的150例患者,分为慢性乙型肝炎组50例,慢性丙型肝炎组50例,原发性肝癌组50例,同期选取50例健康体检者作为正常对照组。
分别采用日本LUMIPULSE G1200全自动免疫分析仪检测血清PIVKA-Ⅱ浓度,德国罗氏Cobas e601全自动电化学发光免疫分析仪检测血清甲胎蛋白(alpha fetoprotein,AFP )浓度。
结果 原发性肝癌组血清PIVKA-Ⅱ和AFP 浓度均明显高于慢性肝病组和正常对照组(P < 0.05)。
PIVKA-Ⅱ诊断原发性肝癌的敏感性为94.0%,特异性为95.3%;AFP 诊断原发性肝癌的敏感性为76.0%,特异性为90.0%。
受试者工作特征曲线(ROC )分析结果显示,PIVKA-Ⅱ和AFP 诊断原发性肝癌的曲线下面积分别为0.963和0.848。
结论 血清PIVKA-Ⅱ诊断原发性肝癌的临床价值优于AFP,值得临床研究推广。
[ 关键词 ] 肝细胞癌; 慢性乙型肝炎; 慢性丙型肝炎; 异常凝血酶原; 甲胎蛋白[ 中图分类号 ] R735.7 [ 文献标志码 ] A [ 文章编号 ] 2095 − 610X (2020)12 − 0080 − 05Diagnostic Efficacy of Serum PIVKA-Ⅱ Detection inPrimary Hepatocellular CarcinomaYUAN Li-xian 1),ZHANG Hong-tao 1),LI Rui 2),CHEN Kun-rui 3),CHEN Kun-qian 4),XU An-shu 5)(1) Dept. of Nuclear Medicine ; 2) Dept. of the Medical Affairs ; 3) Dept. of Infectious Diseases ;4) Dept. of Cardiovascular Surgery ; 5) Dept. of General Surgery, Qujing Affiliated Hospital ofKunming Medical University, Qujing Yunnan 655000, China )[Abstract ] Objective To explore the diagnostic efficacy of serum Protein induced by vitamin K absence or antagonist-Ⅱ(PIVKA-Ⅱ)in Primary hepatocellular carcinoma. Methods 150 patients who diagnosed and treated in Qujing Affiliated Hospital of Kunming Medical University were divided into chronic hepatitis B group (HBV, n = 50), chronic hepatitis C group (HCV, n = 50)and Hepatocellular carcinoma group (HCC, n = 50),and 50 healthy people were selected as normal control group. Serum PIVKA-Ⅱ concentration were detected by Fujirebio-Lumipulse G1200 system and alpha fetoprotein (AFP )concentration were detected by Roche Cobas e601immunoassay system. Results The serum PIVKA-Ⅱ and AFP concentrations in HCC group were significantly higher than those in chronic liver disease groups and normal control group (P < 0.05). The sensitivity and specificity of PIVKA-Ⅱ in the diagnosis of HCC were 94.0% and 95.3%, compared with AFP’ s 76.0% and 90.0% for specificity, respectively. Subjects operating characteristic curve (ROC )showed that the areas under curve of PIVKA-Ⅱ and AFP were 0.963 and 0.848, respectively. Conclusions The diagnostic efficacy of Serum PIVKA-Ⅱ is better than AFP in diagnosing Primary Hepatocellular Carcinoma and can be used in clinical practice.[收稿日期] 2020 − 04 − 16[基金项目] 白求恩医学研究基金资助项目(BY201603-04)[作者简介] 袁丽仙(1981~),女,云南富源人,医学硕士,主治医师,主要从事内分泌激素及肿瘤标志物的研究工作。
同种异体子宫内膜异位症大鼠模型用于GnRH激动剂类药物的药效评价研究
DOI:10.12300/j.issn.1674-5817.2023.150实验动物与比较医学 Laboratory Animal and Comparative Medicine Apr .2024, 44(2)朱 焰,博士,研究员,上海市生物医药技术研究院,生殖药理研究组组长,复旦大学生殖药理专业硕士生导师,国家卫生健康委员会生育调节药械重点实验室课题组组长,中国药理学会生殖药理专委会主任委员、中药与天然药物药理专委会委员,中国优生优育协会生育力保护与修复专委会委员,上海市药理学会生殖药理专委会主任委员,《中药药理与临床》杂志编委。
擅长不孕不育治疗、避孕节育以及子宫内膜异位症、卵巢功能早衰等生殖系统疾病和生殖器官肿瘤动物模型的构建,同时开展药效评价及药理机制研究。
参与“十一五”~“十三五”国家支撑和重点研发项目,负责上海市自然科学基金等多个研究项目。
主持和参与完成50余项药物治疗效果和代谢动力学研究,以及30余项临床前药物安全性评价工作。
发表论文近100篇,其中SCI论文近30篇;获8项专利授权;参编《药理实验方法学》等著作3部。
同种异体子宫内膜异位症大鼠模型用于GnRH 激动剂类药物的药效评价研究钟瑞华1, 李国停1, 杨文捷1, 郭湘洁1, 周洁芸1, 胡颖怡1, 倪其承1,2, 杨野1,2, 张敏3, 朱焰1(1. 国家卫生健康委员会生育调节药械重点实验室, 上海生殖健康药具工程技术研究中心, 上海市生物医药技术研究院生殖药理组, 上海 200237; 2. 复旦大学药学院, 上海 200032; 3. 长春金赛药业有限公司, 长春 130012)[摘要] 目的 用同种异体移植的方法构建大鼠子宫内膜异位症模型,并评价促性腺激素释放激素(gonadotropin-releasing hormone,GnRH )激动剂GenSci006对实验大鼠子宫内膜异位症模型的影响。
方法 取供体SPF 级雌性SD 大鼠的子宫内膜移植于受体雌性大鼠的腹腔壁上,构建同种异体的子宫内膜异位症模型。
临床英语
英语重点, 体温表本贴收到1朵鲜花CLINICAL MED ENGLISH英语基本都在里面了,我们那年多了个单词“体温表”中翻英I. WORDS LISTII. PARAGRAPH TRASLATIONi.The patient-physician interaction proceeds through many phases of clinical reasoning and decision making.--- while respecting individual variations among different patients.医患沟通需要通过多阶段的临床循证和决策来进行。
这种沟通始于对担忧或关注的事物的阐述,接着进行咨询或评价,从而以更精确的方式处理这些所关注的事物。
这个过程通常要求了解详细的病史或体格检查,需要进行诊断性试验,结合临床发现和试验结果,了解各种行为过程可能的益处与风险,并与患者和家属仔细商议从而制定今后的计划。
医生越来越依靠不断增加的循证医学文献来指导这一过程,为的是使患者获益最大化,并能注重不同患者间个体的差异。
ii.Fourth, cognitive impairment increases in prominence as people age. --- Cognitive impairment complicates diagnosis and requires additional care giving to ensure safety.第四方面,认知损害会随着年龄的增长而逐渐凸显。
认知损害是一系列不良后果的危险因素之一,包括摔跤,运动不能,依赖他人,居住于社会慈善机构以及死亡。
认知损害使得诊断变得复杂,并需要额外的看护以确保病人安全。
iii.In the face of continued blood loss and no identified etiology, intraoperative endoscopy may provide simultaneous diagnosis and therapy. During the procedure, the surgeon plicates the bowel over the endoscope. --- and the patient requires long-term transfusion therapy.当出血继续而无法确定病因时,术中内窥镜检查可以同时提供诊断和治疗。
罗氏转染试剂说明书
罗⽒转染试剂说明书X-tremeGENE HP DNA Transfection ReagentFor transient and stable transfection of eukaryotic cellsVersion 05Content version: May 2011Cat. No. 06 365 752 001Cat. No. 06 366 244 001Cat. No. 06 366 236 001Cat. No. 06 366 546 001Trial-pack 0.4 ml 1 ml 5 ×1 mlStore at –15 to –25°C1.What this Product DoesNumber of TestsUsing the standard procedure, 1 ml of X-tremeGENE HP DNA Trans-fection Reagent can be used to perform up to 10,000 transfections in 96-well plates.FormulationX-tremeGENE HP DNA Transfection Reagent is a proprietary blend of lipids and other components supplied in 80% ethanol, filtered through 0.2 ?m pore size membrane, and packaged in glass vials. It does not contain any ingredients of human or animal origin.Storage and StabilityStore X-tremeGENE HP DNA Transfection Reagent at –15 to –25°C, with the lid tightly closed. The reagent is stable until the expiration date printed on the label when stored under these conditions.L X-tremeGENE HP DNA Transfection Reagent remains fully func-tional even after repeated opening of the vial (at least five times over a two-month period), as long as the vial is tightly recapped and stored at -15 to -25°C.L Note that the shipping temperature of this product is differentfrom the storage temperature. These different temperatures will not affect product performance or product stability.Special HandlingN After removing the amount required, tightly close the vial with thelid immediately after use.N Always bring the vial to +15 to +25°C and mix X-tremeGENE HPDNA Transfection Reagent prior to removing the amount required vortexing for one second.N Do not aliquot X-tremeGENE HP DNA Transfection Reagent; storein the original glass vials.N Minimize the contact of undiluted X-tremeGENE HP DNA Trans-fection Reagent with plastic surfaces.N For use, the minimum amount of X-tremeGENE HP DNA Transfec-tion Reagent: DNA complex is 100 µl. Complex formation at lower volumes can significantly decrease transfection efficiency.N Do not use tubes or microplates made of polystyrene forX-tremeGENE HP Transfection Reagent : DNA complex prepara-tion. When not able to avoid polystyrene materials, make certain to pipet the transfection reagent directly into the serum-free medium (e.g., Opti-Mem).N Do not use siliconized pipette tips or tubes.Additional reagents and equipment required to perform transfection assays using X-tremeGENE HP DNA Transfection Reagent include:?Standard Laboratory Equipment .Standard cell culture equipment (e.g., biohazard hoods, incuba-tors)Standard pipettes and micropipettes Vortex mixerFor Plasmid PreparationPurified plasmid stock (0.1 – 2.0 µg/µl) in sterile TE (10 mM Tris, 1 mM EDTA, pH 8.0) buffer or sterile waterGenopure Plasmid Midi Kit* or Genopure Plasmid Maxi Kit* to prepare plasmidFor Verification of Vector Function Assay appropriately for transfected geneG-418 Solution* or Hygromycin B* (optional for stable transfec-tion experiments)For Transfection-Complex FormationOpti-MEM I Reduced Serum Medium or serum-free medium Sterile polypropylene tubes or round-bottom 96-well plates Growing CellsSelect subconfluent cultures in log phase for preparation of cell culturesQuantify cell number to reproducibly plate the same number of cells ApplicationX-tremeGENE HP DNA Transfection Reagent is a high performance transfection reagent, free of animal-derived components. Benefits of X-tremeGENE HP DNA Transfection Reagent include:Designed to transfect a broad range of eukaryotic cells, including insect cells, many cell lines not transfected well by other reagents, and hard-to-transfect cell lines (e.g., HT-1080, K-562, HepG2).Can be successfully used in a variety of applications, such as gene expression analysis and protein production using transiently trans-fected cells, generation of stable cell lines, expression of shRNA for gene knockdown studies, drug discovery programs, and target evaluation. Samples and detailed transfection protocols are avail-able at/doc/48879f4bad02de80d4d840ed.html .Produces minimal cytotoxicity or changes in morphology when ade-quate numbers of cells are transfected, eliminating the requirement to change media after adding the transfection complex.?Suitable for transient and stable transfection. Functions very well in the presence or absence of serum.For life science research only.Not for use in diagnostic procedures.Print2.How to Use this Product2.1Before You BeginRequired Amount of X-tremeGENE HP DNA Transfection ReagentTo optimize, first transfect a monolayer of cells that is 70 - 90% conflu-ent, using 1:1, 2:1, 3:1 and 4:1 ratios of microliter (?l) X-tremeGENE HP DNA Transfection Reagent to microgram (?g) DNA. A ratio of 3:1 of microliter (?l) X-tremeGENE HP DNA Transfection Reagent to micro-gram (?g) DNA has been shown to be optimal for many cell types.L Lower cell confluencies have also been tested successfully.The recommended starting concentration is a 3:1. For most cell types, these X-tremeGENE HP DNA Transfection Reagent to DNA ratios pro-vide excellent transfection efficiency.L Further optimization may increase transfection efficiency in your particular application. In addition to varying the ratio, other param-eters may also be evaluated, such as the amount of transfection complex added. For additional optimization guidelines, see Section 3, Troubleshooting and visit /doc/48879f4bad02de80d4d840ed.html .For best results, accurately determine the plasmid DNA concentra-tion using 260-nm absorption; estimates of DNA by measuring gel band density are not recommended. Determine DNA purity using a 260 nm/280 nm ratio (the optimal ratio is 1.8).Prepare the plasmid DNA solution using sterile TE (Tris/EDTA) buf-fer or sterile water at a concentration of 0.1 to 2.0 µg/µl. Use high quality DNA preparation kits to obtain endotoxin-free DNA.Cell Culture ConditionsMinimize intra- and inter-experimental variance in transfection effi-ciency using cells that are regularly passaged, proliferating well in a log-growth phase, and plated at a consistent density.For best results, accurately quantify cell concentration using a hematocytometer or automated system.Cells must be healthy and free of Mycoplasma.Cells should have a low passage number to achieve best results.Other Media AdditivesIn some cell types, antimicrobial agents (e.g., antibiotics and fungi-cides) commonly included in cell-culture media may adversely affect the transfection efficiency of X-tremeGENE HP DNA Transfection Reagent. If possible, exclude additives in initial experiments. Once high-efficiency conditions have been established, these components can be added back while monitoring transfection results. Cell growth and/or transfection efficiency may be affected by variations in serum quality and medium formulations.Verification of Vector FunctionOptimize transfection conditions using a known positive-control reporter gene construct before transfecting cells with a new vector construct:Determine transfection efficiency using a reporter gene assay, such as -Gal*, Luciferase*, or SEAP*.Sequence flanking vector insert regions to verify the integrity of your new construct.2.2Preparation of Cells for TransfectionAdherent Cells: Plate cells approximately 24 hours before transfec-tion making sure cells are at the optimal concentration in the appropri-ate cell culture vessel.Suspension Cells: Plate freshly passaged cells at optimal concentra-tion.2.3 Transfection ProcedureAllow X-tremeGENE HP DNA Transfection Reagent, DNA and diluent to equilibrate to +15 to +25°C. Briefly vortex theX-tremeGENE HP DNA Transfection Reagent vial.Dilute DNA with appropriate diluent (e.g., serum-free medium) to a final concentration of 1 µg plasmid DNA /100 µl medium (0.01 µg/µl). Mix gently.Place 100 µl of diluent, containing 1 µg DNA into each of four sterile tubes labeled 1:1, 2:1, 3:1, and 4:1.N Use a minimum of 100 µl of diluent. Lower volumes may significantly decrease transfection efficiency.L Use sterile tubes or tissue culture treated round-bottom, 96-well plates to produce the complex.Pipet the X-tremeGENE HP DNA Transfection Reagent (1, 2, 3, or 4 µl) directly into the medium containing the diluted DNA without coming into contact with the walls of the plastic tubes.Mix gently.N To avoid adversely affecting transfection efficiency, do not allow undiluted X-tremeGENE HP DNA Transfection Reagent to come into contact with plastic surfaces. Do notIncubate the transfection reagent:DNA complex for 15 min-utes at +15 to +25°C.L Some ratios and cell types may required longer incubation (up to 30 min). Determine this for your particular cell lineand the ratio used.Remove the culture vessel from the incubator. Removal of growth medium is not necessary. Add the transfection com-plex to the cells in a dropwise manner.L See Table 1 to determine component amounts corre-sponding to the surface area of the cell culture vesselused.Gently shake or swirl the wells or flasks to ensure even distri-bution over the entire plate surface. If available, use a rotatingplatform shaker for 30 seconds at low speed for mixing96-well plates.Once the transfection reagent: DNA complex has been addedto the cells, there is no need to replace with fresh medium (asmay be necessary with other transfection reagents)Following transfection, incubate cells for 18 – 72 hours before measuring protein expression. The duration of incubation will depend on many factors, including the transfected vector con-struct, the cell type being transfected, the cell medium, celldensity, and the type of protein being expressed. After theincubation period, measure protein expression using an assayappropriate for your system.Notes:L As with any experiment, include appropriate controls. Prepare cul-ture wells with cells that remain untransfected, cells with transfec-tion reagent alone, and cells with DNA alone.L For stable transfection experiments, the complex-containing medium should be left unchanged until the cells are passaged. At that time, include appropriate selection antibiotics (e.g., G 418 Solution or Hygromycin B).L To prepare transfection complexes for different-sized containers or parallel experiments, adjust component amounts correspond-ing to the surface area of the cell culture vessel used (see Table 1).L For ease-of-use when transfecting small volumes into 96-well plates containing 0.1 ml culture medium per well, prepare 100 µl of transfection complex, and then add 10 µl to each well (depend-ing on cell type).L The optimal ratio of transfection reagent to DNA, and the optimal total amount of complex, will depend on the cell line, cell density, day of assay, and gene expressed.L After performing the optimization experiment in which several dif-ferent ratios are tested, select a ratio in the middle of the plateau optimum for future experiments.Tab. 1: Guidelines for Preparing X-tremeGENE HP DNA Transfection Reagent: DNA Complex for Various Culture Vessel SizesCulture vessel Surface Areamedium (ml) Suggested amount of100 µl transfection complexto add toeach well (µl) DNA (µg)using 1:1or 4:1 RatioFinal amountof X-tremeGENE HP DNA Transfection Reagent (µl) using 1:1 Ratio Final amountof X-tremeGENE HP DNA Transfection Reagent (µl) using 4:1 Ratio 96-well plate(1 well)0.30.1100.10.10.4 48-well plate(1 well)1.00.3300.30.3 1.2 24-well plate(1 well)1.90.5500.50.52 12-well plate(1 well)(1 well)9.42200228 60-mm dish2155005520 10-cm dish55101000101040 T-25 flask2566006624 T-75 flask75202000202080 2.4TroubleshootingObservation Possible Cause RecommendationLow Transfection Efficiency Suboptimal X-tremeGENE HP DNA Transfec-tion Reagent : DNA ratioTitrate optimal X-tremeGENE HP DNA Transfection Reagent : DNAratio. Refer to the text in Section 2.1 “Before you begin”.Insufficient number of cells Determine optimal cell density for each cell type. For most cell types, 70– 90% confluence at transfection is optimal.X-tremeGENE HP DNA Transfection Reagent :DNA complexes did not form wellPrepare complexes in serum-free medium (e.g., Opti-MEM).Do not use siliconized pipet tips or tubes.Do not aliquot the X-tremeGENE HP DNA Transfection Reagent. Incubation time of transfection Determine the optimal incubation time (18 - 72 h). Optimal for most celltypes and plasmids is 24 – 48h.Inhibition by media components Some media components (e.g., polyanions) may influence the transfec-tion.Low volume of X-tremeGENE HP DNA Trans-fection Reagent : DNA complexThe minimum amount of X-tremeGENE HP DNA Transfection Reagentto DNA complex is 100 µl. Complex formation at lower volumes may sig-nificantly decrease the transfection efficiency; refer to the text in Section1, “Special Handling”.High Cytotoxicity Cell density not optimal For each cell type, the optimal density should be determined. For mostcell types, 70 - 90 % confluence at transfection is recommended, butother confluencies may increase cell viability.Cells are cultured in serum-free medium Transfection using X-tremeGENE HP DNA Transfection Reagent in cells cultured in serum-free medium is possible, however, toxicity may behigher when serum is absent.X-tremeGENE HP DNA Transfection Reagent : DNA complexes and cells not mixed well Add X-tremeGENE HP DNA Transfection Reagent dropwise to the cells. Gently rock the dish/plate back and forth and from side to side to evenly distribute the complexes.Plasmid preparation contaminated with endo-toxinTransfected protein is cytotoxic or is produced at high levels Reduced viability or slow growth rates may be due to high levels of pro-tein expression, with cellular metabolism directed toward production of the heterologous protein. Note that the expressed protein may also be cytotoxic at the expressed levels.Too much transfection complex for number of cells Increase the number of plated cells, and/or decrease the total amount of complex added to the cells.3.Additional Information on This ProductQuality ControlEach lot of X-tremeGENE HP DNA Transfection Reagent is tested using established quality control procedures. Functional AnalysisCells are transfected with a reporter gene vector DNA using X-tremeGENE HP DNA Transfection Reagent (ratio 3:1 µl/µg DNA). Reporter gene activity is monitored by chemiluminescent detection. Using a standard curve analysis method, total amounts of recombinant protein per well are measured to ensure levels that are within specifi-cation.4.ResultsCHO-K1 cells were transfected with a GFP encoding pcDNA3.1 plas-mid containing a CMV promoter with two different transfection reagents. CHO-K1 cells were observed under fluorescence and bright field microscopy at 10× magnification. Pictures were obtained using the Cellavista System 24 hours after transfection.Fig. 1:X-tremeGENE HP DNA Transfection Reagent (1:1 ratio)Fig. 2:Competitor transfection reagent (2:1 ratio)5.Supplementary InformationConventionsIn this document, the following symbols are used to highlight impor-tant information:Symbol DescriptionL Information Note:Additional information about the current topic or proce-dure.N Important Note:Information critical to the success of the procedure or useof the product.Text ConventionsTo make information consistent and understandable, the following textText Convention UseNumbered instructionslabeled ?, ? etc.Steps in a procedure that must be performedin the order listed.Changes to Previous VersionEditorial changesOrdering InformationRoche Applied Science provides a large selection of reagents and sys-tems for life science research. For a complete overview of relatedproducts and manuals, visit and bookmark our home page,/doc/48879f4bad02de80d4d840ed.html , and our Special Interest Site on transfection, /doc/48879f4bad02de80d4d840ed.htmlAsterisk *Denotes a product available from Roche AppliedScience.Product Pack Size Cat. No.Apoptosis and Cell Death ProductsCell ProliferationReagent WST-125 ml (2,500 tests)8 ml (800 tests)11 644 807 001***********Cytotoxicity DetectionKit PLUS (LDH)1 kit 400 tests in 96 wells1 kit 2,000 tests in 96 wells**********************Gene Knockdown ReagentX-tremeGENE siRNATransfection Reagent1 ml (400 transfections in a24-well plate)Mycoplasma Detection ReagentsMycoplasma DetectionKit1 kit (25 tests)11 296 744 001Mycoplasma PCR ELISA1 kit (96 reactions)11 663 925 910 Plasmid Isolation ProductsGenopure Plasmid MidiKit1 kit (for up to 20 prepara-tions)***********Genopure Plasmid MaxiKit1 kit (for up to 10 prepara-tions)***********Protease Inhibitor T ablets and Lysis Reagents cOmplete20 tablets in glass vials3 x 20 tablets in glass vials20 tablets in EASYpacks11 697 498 00111 836 145 001***********cOmplete, EDTA-free20 tablets in a glass vial3 x 20 tablets in glass vials20 tablets in EASYpacks11 873 580 001**********************cOmplete Lysis-M (formammalian cell lysis)1 kit (200 ml lysis reagentand 20 complete ProteaseInhibitor Cocktail Tablets)Roche Diagnostics GmbH Roche Applied Science 68298 Mannheim GermanyContact and SupportTo ask questions, solve problems, suggest enhancements or report new applications, please visit our Online Technical Support Site at:/doc/48879f4bad02de80d4d840ed.html /supportTo call, write, fax, or email us, visit the Roche Applied Science home page,/doc/48879f4bad02de80d4d840ed.html , and select your home country. Country- specific contact information will be displayed. Use the Product Search func-tion to find Pack Inserts and Material Safety Data Sheets. Regulatory DisclaimerFor life science research only.Not for use in diagnostic procedures.TrademarksCOMPLETE, GENOPURE, X-TREMEGENE, XCELLIGENCE, CASY, CEDEX, and CELLAVISTA are trademarks of Roche. E-PLATE and ACEA BIOSCIENCES are registered trademarks of ACEA Biosciences, Inc. in the US.Other brands or product names are trademarks of their respective holders.cOmplete Lysis-M,EDTA-free (for mammalian cell lysis) 1 kit (200 ml lysis reagent and 20 complete, EDTA-free Protease Inhibi-tor Cocktail Tablets)04 719 964 001Reporter Gene Assays CAT ELISA1 kit (192 tests)11 363 727 001-Gal Reporter Gene Assay,chemiluminescent 1 kit (500 assays, micro-plate format, 250 assays, tube format)11 758 241 001?-Gal ELISA 1 kit (192 tests)11 539 426 001hGH ELISA1 kit (192 tests)11 585 878 001Luciferase Reporter Gene Assay, high sensi-tivity200 assays 1,000 assays 11 669 893 00111 814 036 001SEAP Reporter Gene Assay,chemiluminescent 1 kit (500 assays, micro-plate format, or 250 assays, tube format)11 779 842 001Selection Antibiotics G-418 Solution 20 ml 100 ml 04 727 878 00104 727 894 001Hygromycin B1 g (20 ml)10 843 555 001Transfection Reagents X-tremeGENE 9 DNA Transfection Reagent0.4 ml 1 ml 5 x 1 ml 06 365 779 00106 365 787 00106 365 809 001Western Blotting ReagentsLumi-Light PLUS Western Blotting Kit(Mouse/Rabbit)1 kitLumi-Light PLUS Western Blotting Substrate100 ml(1,000 cm 2 membrane)12 015 196 001PVDF Western Blotting Membranes 1 roll(30 cm × 3.00 m)03 010 040 001Western Blocking Reagent, Solution100 ml(10 blots, 100 cm 2)6 × 100 ml(60 blots, 100 cm 2)11 921 673 00111 921 681 001Cellular Analysis RTCA Analyzer 05 228 972 001RTCA SP Station 05 229 057 001RTCA MP Station 05 331 625 001RTCA Control Unit 1.105 454 417 001E-Plate 96 6 Units 6 x 6 Units 05 232 368 001 05 232 376 001E-Plate VIEW 96 6 Units 6 x 6 Units06 472 451 001 06 472 460 001Cellavista BasicMagnification: 4x, 10x Illumination: Brightfield only***********Cellavista Medium Magnification: 4x, 10x, 20xIllumination: Brightfield and Fluorescence, UV, Blue, Green***********Product Pack Size Cat. No.Cellavista High End Magnification: 2x, 4x, 10x, 20x, 40xIllumination: Brightfield and Fluorescence,UV, Blue, Cyan, Green, Amber, Red***********Cedex XS Analyzer with Control Unit 05 926 432 001Cedex Smart Slide package15 x 8measurements05 650 801 001CASY Model TT 45, 60, 150 µm***********ProductPack Size Cat. No.。
IgG4相关唾液腺炎临床诊疗特点
IgG4相关唾液腺炎临床诊疗特点王知俊;俞创奇;郑凌艳;浦益萍;谢李松;石欢【摘要】目的:探讨IgG4相关唾液腺炎的临床特点、诊断和治疗方法.方法:回顾性分析10例IgG4相关唾液腺炎患者临床检查、血清学、病理学和B超检查资料,并观察随访小剂量糖皮质激素疗效.结果:10例IgG4相关唾液腺炎患者均表现为双侧唾液腺持续、对称、无痛性肿大,血清IgG4浓度异常升高,可伴有腺体IgG4+浆细胞浸润合并组织纤维化或硬化;自身抗体均为阴性;B超表现腺体常呈蜂窝状弥漫性病变;小剂量糖皮质激素口服治疗,短期疗效明显.结论:IgG4相关唾液腺炎有其特有的临床表现,应注意与舍格伦综合征(简称SS)和唾液腺肿瘤相鉴别,短期内小剂量糖皮质激素治疗有效.【期刊名称】《口腔颌面外科杂志》【年(卷),期】2013(023)006【总页数】6页(P432-437)【关键词】IgG4;IgG4相关疾病;唾液腺炎;诊断;治疗【作者】王知俊;俞创奇;郑凌艳;浦益萍;谢李松;石欢【作者单位】上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011;上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011;上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011;上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011;上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011;上海交通大学医学院附属第九人民医院口腔颌面外科,上海市口腔医学重点实验室,上海,200011【正文语种】中文【中图分类】R781.72IgG4相关疾病是一类新近被认识的与IgG4+淋巴浆细胞密切相关的慢性系统性疾病,以病变组织弥漫性肿大、密集的淋巴浆细胞浸润(其中富含IgG4+浆细胞)、组织纤维化为特征,常伴有血清IgG4浓度升高。
单双极电极系统宫腔镜手术对患者体液平衡影响的比较
新的器械来尽可能避免并发症的发生,双极电极系统被应用到宫腔镜手术领域。
◇士、-毫。!
单积极电极系统富腔镜手术对患者体渡平衡影响的比较
双极电极系统,电流只是通过器械电极两个顶端之间的组织形成回路,在电极所 接触的局部组织产生电功效,不会影响机体其他非接触部位组织,从而避免电损 伤。另外,双极电极系统应用电解质液生理盐水作为膨宫液,从理论上可以避免 非电解质膨宫液所致的相关并发症。文献报道,生理盐水被吸收进入血循环,可 能不会引起明显的电解质变化,但过量吸收生理盐水仍然有可能发生肺水肿或脑 水肿导致昏迷或死亡。所以,手术过程中必须注意并记录膨宫液的吸收量。
宫腔镜手术需要连续灌注膨宫液和应用高频电发生器双重条件才能完成。 2004年以前,宫腔镜手术主要应用单极高频电发生器及单极电极系统。电极系 统的主要特点就是电流由正极经过人体回流至负极,形成完整电流回路,产生功 效。单极系统的旁路电流,或者器械绝缘不良时发生的电流扩散可能引起生殖道 或者内脏的电损伤。Vivek等指出,当绝缘失败时,100%的电流经过电切镜的 外鞘传导从而引起生殖道的电损伤,即使在绝缘良好的情况下,仍有20%的电 流通过电切镜的外鞘分流。因此,不论器械是否绝缘良好,单极系统存在潜在的 电损伤。单极电极系统的另一特点是必须使用非电解质膨宫液,一般是低渗溶液, 过量吸收将导致电解质的改变、肺水肿、充血性心衰、脑水肿甚至死亡。因此类 并发症首先出现在经尿道前列腺电切术,将其命名为经尿道前列腺电切综合症
system during Operative Hysteroscopies
Major:Gynecology and Obstetrics Name:Guan Mingfei
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Exp. Anim. 59(2), 231–237, 2010Variations of Serum Estradiol and Progesterone Levels during Consecutive Reproductive States in Mongolian Gerbils (Meriones unguiculatus )Xiao Hui LV and Da Zhao SHICollege of Agriculture and Biotechnology, China Agricultural University, Beijing 100193, ChinaAbstract: Serum estradiol (E2) and progesterone (P4) levels were measured by chemiluminescence immunoassay (CLIA) during consecutive reproductive states in Mongolian gerbils. The results show that E2 and P4 levels throughout the estrous cycle in Mongolian gerbils peaked at proestrus and estrus, respectively. During gestation in primiparous and multiparous gerbils, E2 levels reached a small peak on day 6 and a maximum peak on day 21, followed by a slight decline until parturition. Thereafter, they dropped sharply during the first 3 days of lactation and remained stable until lactation ended. P4 levels reached a peak on day 12 during gestation in primiparous gerbils, while they peaked on day 6 in multiparous gerbils. The levels of P4 then decreased until parturition. During lactation, P4 levels peaked on day 9 in primiparous gerbils, while they peaked on day 6 in multiparous gerbils, and then the levels declined gradually until lactation ended. The findings suggest that the variations of E2 levels during the estrous cycle, gestation and lactation in Mongolian gerbils are similar to those observed in rats and mice. Changes in E2 levels during different reproductive states were the same in the primiparous and multiparous gerbils, but the variations in P4 levels did not display this tendency. Changing patterns of E2 and P4 levels are suitable for the reproductive stages of Mongolian gerbils.Key words: estradiol, estrous cycle, gestation, lactation, progesterone(Received 31 August 2009 / Accepted 18 December 2009)Address corresponding: D.Z. Shi, College of Agriculture and Biotechnology, China Agricultural University, No. 2 Yuanmingyuan West Road, Haidian District, Beijing 100193, ChinaIntroductionThe Mongolian gerbil (Meriones unguiculatus Milne Edwards, 1867) belongs to the subfamily Gerbillinae , and is mainly distributed across the arid steppes, semi-deserts and adjacent farming-pastoral areas of North China, Mongolia, and the Baikal Lake region of Russia [17, 21, 35]. Its population is volatile and these gerbils cause serious damage to crops of farming areas when they are present in large numbers. They are also themain reservoir host of plague [17, 35]. Because of the special characteristics of the Mongolian gerbil, it has become an extensively used experimental animal, for example, in neuroscience, physiology, pharmacological, parasitological, and endocrinological research [21]. The estrous cycle of the Mongolian gerbil is 4 to 7 days, pregnancy is 24 to 26 days, lactation is 21 to 22 days, and the litter size at birth ranges from 1 to 9 offspring [11, 12, 18, 22]. We can further understand the reproduc-tive characteristics of Mongolian gerbils through studies—Original—232X.H. LV aND D.Z. SHIof reproductive hormones. However, there are only a few reports on the secretion patterns of reproductive hormones during different reproductive states in Mon-golian gerbils [6, 11, 12, 22, 24]. The aims of this study were, first, to confirm the variations of serum estradiol (E2) and progesterone (P4) levels in different reproduc-tive states of Mongolian gerbils and to analyze the dif-ferences of E2 and P4 patterns between Mongolian gerbils and other rodents such as rats and mice; second, to analyze the differences in variations of E2 and P4 levels in primiparous and multiparous gerbils; and third, to analyze the relationships between the two hormone levels and the reproductive states of Mongolian ger-bils.Materials and Methods Animals and samplingMongolian gerbils used in this study were indoor breeding individuals whose parents were captured in the Xilinguole League of Inner Mongolia. The gerbils were maintained at 20 ± 3°C with automatically controlled lighting from 0700 to 2100 h (14L:10D). They were provided with a food mixture containing equal parts of corn and sunflower seeds, and they were given water ad libitum. Eight 4-month-old virgin female gerbils (55–65 g) with regular estrous cycles of 4 days as confirmed by vaginal smear were used [22]. The virgin female gerbils were paired with experienced males in the afternoon and were examined by vaginal smear the next morning. The day on which sperm were found in the vaginal smear was designated as day 0 of gestation. The male was removed when the female was confirmed as pregnant. The parturition day was regarded as the last day of ges-tation and day 0 of lactation. The day when the pups were able to obtain food by themselves was regarded as the last day of lactation. The mean gestation period of the Mongolian gerbils in the present study was 24.1 ± 0.1 days (24 days: n=7; 25 days: n=1). The time from the end of lactation in primiparous gerbils to the estrous cycle in multiparous gerbils was about two weeks. Blood sampling from female gerbils began in the vir-gin estrous cycle, and continued through gestation and lactation of primiparous gerbils, the post-weaning es-trous cycle, and the gestation and lactation of multipa-rous gerbils. Blood samples were taken every day dur-ing the estrous cycle and every 3 days during gestation and lactation. The sampling was conducted 42 times in each gerbil on the premise of its normal survival. Blood samples (0.2–0.3 ml) were collected between 1400 and 1500 h via the orbital venous sinus following light ether anaesthesia. Serum was separated by centrifugation at 1,000 ×g for 20 min at 4°C and stored at –80°C until analysis. The gerbil handling and tests were performed according to the Guide for the Care and Use of Labora-tory animals.Hormone assaysSerum E2 and P4 levels were determined by a chemi-luminescence immunoassay (CLIa) using commercial kits for CLIa (Furui Biotechnology Co., Ltd., Beijing, China). The sensitivity was 30–2,000 pg/ml for estra-diol and 0.25–80 ng/ml for progesterone. The intra-assay variations for both were less than 10%, while both inter-assay variations were less than 15%.Statistical analysesData distributions were analyzed for normality by the one-sample Kolmogorov-Simirnov test. The hormone data were analyzed by one-way aNOV a (SPSS for Win-dows 11.5) for repeated measures. Pearson correlation coefficients were calculated between E2 and P4 levels per reproductive state. Linear regression was tested between E2 and P4 levels and the number of pups. Val-ues were considered as statistically significant at P<0.05 and highly significant at P<0.01. Data are presented as means ± SEM (n=8).ResultsHormonal variations during the estrous cycle of virgin gerbils and during gestation and lactation in primiparous Mongolian gerbils (Fig. 1)Serum E2 during the estrous cycle of virgin gerbils reached a peak at proestrus (73.12 ± 4.19 pg/ml, P<0.05) and displayed no significant differences throughout es-trus (60.82 ± 4.66 pg/ml), metestrus (59.35 ± 4.44 pg/ ml), and diestrus (58.74 ± 3.40 pg/ml). Serum P4 re-mained constant through proestrus (3.08 ± 0.49 ng/ml),233HORMONaL VaRIaTIONS aND REPRODUCTIVE STaTESmetestrus (3.07 ± 0.55 ng/ml), and diestrus (2.92 ± 0.52 ng/ml), peaking at estrus (5.08 ± 0.87 ng/ml, P <0.05).Serum E2 of primiparous gerbils was low on day 0 of gestation (61.70 ± 2.67 pg/ml) when sperm were ob-served in the vaginal smear. Then, it slowly increased during early gestation, reaching a minor peak on day 6 (79.45 ± 13.27 pg/ml), then remained stable from day 6 to day 18 of gestation (75.06 ± 6.20 pg/ml). During later gestation, a sharp increase in the E2 was seen that reached a maximum on day 21 (132.23 ± 11.68 pg/ml) after which it decreased to a relatively high level on the day of parturition (107.43 ± 5.85 pg/ml). Serum P4 was also low on day 0 of gestation (3.52 ± 0.66 ng/ml) but rapidly rose until day 6 (20.83 ± 1.83 ng/ml). Subse-quently, serum P4 continued rising and reached a maxi-mum on day 12 (25.82 ± 1.95 ng/ml). Thereafter it declined and reached its lowest point on the day of par-turition (6.79 ± 1.05 ng/ml). Serum P4 was higher dur-ing the fi rst half of gestation than during the second half of gestation in primiparous gerbils. Serum E2 levels were negatively correlated with P4 levels (r =–0.560, P <0.01) in the second half of gestation, while the cor-relation coeffi cients during other gestation periods were not signifi cant in primiparous gerbils (P >0.05).Serum E2 gradually fell from day 0 of lactation (107.43 ± 5.85 pg/ml) to day 3 (74.62 ± 6.42 pg/ml) in primiparous gerbils. Subsequently, it remained stable from day 3 to day 24 (68.90 ± 2.82 pg/ml) without sig-nifi cant changes during this period (P >0.05). Duringlactation serum P4 gradually increased from day 0 andreached a peak on day 9 (13.27 ± 3.13 ng/ml). It dropped on day 12 (8.13 ± 1.34 ng/ml) and then remained rela-tively stable until day 24 (5.54 ± 0.75 ng/ml, P >0.05). There was no signifi cant correlation between serum E2 levels and serum P4 levels during lactation in primipa-rous gerbils (P >0.05).Hormonal variations during the post-weaning estrous cycle, gestation and lactation in multiparous Mongolian gerbils (Fig. 2)During the post-weaning estrous cycle, serum E2 reached a peak at proestrus (95.81 ± 17.47 pg/ml, P <0.05), but there were no significant differences throughout estrus (63.80 ± 5.52 pg/ml), metestrus (51.02 ± 6.84 pg/ml), and diestrus (49.13 ± 5.20 pg/ml). Serum P4 remained constant through proestrus (6.57 ± 1.35 ng/ml), metestrus (5.41 ± 0.67 ng/ml), and diestrus (6.95 ± 1.12 ng/ml) before reaching its maximum at estrus (12.08 ± 2.75 ng/ml, P <0.05).In multiparous gerbils, the serum E2 level during ges-tation gradually increased from day 0 (47.24 ± 5.37 pg/ml), and reached a small peak on day 6 (68.87 ± 7.58 pg/ml). It then sharply rose to a maximum (174.70 ± 27.58 pg/ml) on day 21. Subsequently, serum E2 dis-played a slight decline from day 21 to the day of partu-rition (163.47 ± 29.03 pg/ml). Serum P4 showed a rapid rise from 5.05 ± 1.41 ng/ml on day 0 to a peak onday 6 (24.24 ± 3.19 ng/ml). after day 6, serum P4 ex-Fig. 1. Serum E2 and P4 levels during the virgin estrus cycle, gestation, and lactation in primiparousMongolian gerbils. Each point represents the mean ± SEM of 8 gerbils. (P, E, M, D=proestrus, estrus, metestrus, disestrus. Gestation: 0–21 and lactation: 0–24.)234X.H. LV aND D.Z. SHIhibited a gradual decline and reached moderate levels (12.49 ± 1.40 ng/ml) on day 12. During the second half of gestation in multiparous gerbils, the P4 level con-tinuously decreased and reached a minimum on the day of parturition (5.60 ± 0.88 ng/ml). Serum E2 levels were negatively correlated with serum P4 levels (r =–0.334, P <0.05) during gestation in multiparous gerbils.During lactation, serum E2 showed a rapid fall from day 0 (163.47 ± 29.03 pg/ml) to day 3 (70.11 ± 6.57 pg/ml). Subsequently, it remained stable from day 3 to day 24 (63.04 ± 4.24 pg/ml), without any signifi cant differ-ences (P >0.05) during this time period. Serum P4 gradually increased from day 0 (5.60 ± 0.88 ng/ml) and reached a peak on day 6 (10.99 ± 3.35 ng/ml) of lactation. It then fell and remained relatively stable from day 18 (4.65 ± 0.47 ng/ml) to day 24 (4.25 ± 0.30 ng/ml). There was no signifi cant correlation between serum E2 levels and serum P4 levels (P >0.05) during lactation in mul-tiparous gerbils.Regression between estradiol and progesterone levels and the number of littersIn each primiparous gerbil, the mean number of the litter was 6.3 ± 0.3 (5–8 pups), with 2.6 ± 0.2 females and 3.6 ± 0.3 males, while the mean number of the litter was 6.1 ± 0.4 (4–8 pups), with 2.1 ± 0.4 females and 3.9 ± 0.3 males per multiparous gerbil. There was no sig-nifi cant linear regression between the mean number of the litter for each primiparous and multiparous gerbiland the serum E2 and P4 levels at the following times: days 6, 9, 12, and 21 of gestation and days 0, 3, 6, and 9 of lactation.DiscussionHormonal variations during the estrous cycle in virgin Mongolian gerbilsThe changes of E2 and P4 levels during the estrous cycle correlated with the ovulation of Mongolian gerbils. The Mongolian gerbil is a spontaneous ovulation animal. a spontaneous ovulation animal is considered to be one that undergoes estrogen secretion earlier than progester-one release [16], while the progesterone peak is earlier than the ovulation time [19]. Most matings of Mongolian gerbils were observed from 1700 to 2000 h, and ovula-tion occurred between 6 and 10 h after mating [18, 22]. The peak of E2 at proestrus leads to an increase of go-nadotropin releasing hormone (GnRH) level triggering the luteotropin (LH) peak of preovulation. The LH peak causes P4 to increase, and P4 eventually peaks at estrus. The phase during which P4 peaks during the estrous cycle in Mongolian gerbils is different from those of rats and mice, in which the peak appears at proestrus [9, 29]. This difference may be caused by the difference in ovu-lation time. Contrary to the results of this study, other work has indicated that serum E2 reaches a peak at di-estrus while serum P4 peaks at estrus in Mongoliangerbils [6]. although the measurement method used wasFig. 2. Serum E2 and P4 levels during the post-weaning estrus cycle, gestation, and lactation in multipa-rous Mongolian gerbils. Each point represents the mean ± SEM of 8 gerbils. (P, E, M, D=proestrus, estrus, metestrus, disestrus. Gestation: 0–21 and lactation: 0–24.)235 HORMONaL VaRIaTIONS aND REPRODUCTIVE STaTESthe same, the standard error of E2 and P4 peak values high, and it was not stated whether or not the female gerbils were virgins.Hormonal variations during gestation in primiparous Mongolian gerbilsThe results obtained in the present study indicate that the changing patterns of serum E2 and P4 levels are suitable for embryo implantation, decidualization, and parturition initiation during gestation in Mongolian ger-bils. Embryo implantation occurs from the night of day 6 through the morning of day 7 during gestation in Mon-golian gerbils [5, 18, 33] and requires the joint action of E2 and P4. The decidualization, which also needs the actions of the E2 and P4 begins shortly after implanta-tion, and the weight and size of the uterus subsequently increase [1]. In Mongolian gerbils, the maternal de-cidual reaction is at its height of development two days after implantation [5]. A higher P4 level during the first half of gestation conditions the uterus environment ap-propriate for embryo development and inhibits the reac-tion of the uterus to estrogen and oxytocin. E2 reached a peak on day 21, while P4 gradually declined prior to parturition. The changing levels of E2 and P4 are re-lated to parturition initiation, which requires a rise in E2 and a decline in P4. The level of P4 declines relative to E2 to allow estrogen to stimulate the rhythmic contrac-tion of the uterus, overcome the progesterone inhibition and raise the myometrial sensitivity to oxytocin. Mean-while, the fall of the P4 level correlates with milk gen-eration and the initiation of maternal behavior [13, 14].The variation of E2 during gestation in Mongolian gerbils is similar to those in rats and mice, in which the E2 level gradually increases during early gestation, reaching a peak during embryo implantation, and then continuously increases, reaching a peak before parturi-tion [3, 15, 26, 32]. In the present study, the pattern of P4 levels during gestation was similar to those observed in previous works [11, 12], but differed from those de-tected in rats and mice. In rats and mice, P4 levels dur-ing the first half of gestation are lower than the levels during the second half of gestation [2, 3, 9, 20].Hormonal variations during lactation in primiparous Mongolian gerbilsNursing pups had a significant effect on variations of E2 and P4 levels during lactation in Mongolian gerbils, but the E2 and P4 levels had no significant linear regres-sion relationships with the mean number of pups for each gerbil on day 0, 3, 6, or 9 of lactation. The suckling stimulus inhibits GnRH release, with the degree of in-hibition related to the suckling intensity, so as to suppress gonadotropin secrection [27, 28]. The serection of es-trogen is eventually restrained, but the physiological estrogen level is stimulative for lactation maintenance. The Mongolian gerbil displays a postpartum ovulation phenomenon [18], and the suckling stimulus during early lactation allows the corpus luteum that is formed after ovulation to become functional and secrete proges-terone [7, 10, 25, 31]. Prolactin (PRL) induced by the suckling stimulus maintains the corpus luteum function and induces continuous P4 secretion [28, 34]. Because of the diminution of the suckling stimulus along with lactation, PRL levels decline, which leads to corpus lu-teum regression and a drop in the P4 level. Changes of E2 and P4 levels during lactation in prim-iparous gerbils were similar to those in rats. The E2 level is significantly high on the day of parturition, sub-sequently declines, and then remains relatively stable until lactation ends [15, 26, 30]. The P4 level is sig-nificantly low on the day of parturition, then gradually rises from early lactation to mid lactation, and declines during late lactation [7, 8, 10, 30].Hormonal variations during different reproductive states in multiparous Mongolian gerbilsVariation of E2 in different reproductive states was the same in multiparous and primiparous gerbils, but changes in P4 were different. During the post-weaning estrous cycle, E2 levels did not change much compared with those in virgin gerbils, and a similar tendency is seen in rats [4]. However, P4 during the post-weaning estrus cycle was higher than during the estrous cycle in virgin gerbils. E2 levels during gestation were not sig-nificantly different in multiparous and primiparous ger-bils, a finding which differs from those for rats. In multiparous rats, E2 during gestation is higher than in primiparous rats [23]. P4 reached a maximum on day 6236X.H. LV aND D.Z. SHIduring gestation in multiparous gerbils, which was dif-ferent from primiparous gerbils. The peak of P4 on day 6 in multiparous gerbils is consistent with the time of embryo implantation. although P4 continuously de-creased after day 6, P4 was still higher during the first half of gestation than during the second half of gestation. During lactation, the change of E2 in multiparous gerbils was similar to that observed in primiparous gerbils. P4 during lactation also reached a maximum value on day 6, earlier than in primiparous gerbils. The reasons for the earlier peak of P4 during gestation and lactation in multiparous gerbils remain unclear.Both estrogen and progesterone are important repro-ductive hormones secreted by the gonad and play im-portant roles in regulating reproduction. Variations of E2 during the estrous cycle, gestation and lactation in Mongolian gerbils and other rodents such as rats and mice are similar, but variations of P4 are not. Changes of E2 during the different reproductive states mentioned above are the same in primiparous and multiparous ger-bils, but changes of P4 are not. additional work is needed to further understand the reasons behind the dif-ferences in the variation of P4.AcknowledgmentsWe thank Prof. YongSong CaO and YanLing WaNG for reviewing this manuscript and critical comments. The work was supported by National Key Basic Research and Development Program of China (No. 2007CB109105), and National Key Technology Research and Develop-ment Program of China (No. 2006BaD16B04-1).References1. abrahamsohn, P.a. and Zorn, T.M. 1993. Implantation anddecidualization in rodents. J. Exp. Zool. 266: 603–628. 2. Barkley, M.S., Geschwind, I.I., and Bradford, G.E. 1979.The gestational pattern of estradiol, testosterone and progesterone secretion in selected strains of mice. Biol.Reprod. 20: 733–738.3. Bridges, R.S. 1984. a quantitative analysis of the roles ofdosage, sequence, and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat.Endocrinology 114: 930–940.4. Byrnes, E.M. and Bridges, R.S. 2005. Lactation reducesprolactin levels in reproductively experienced female rats.Horm. Behav. 48: 278–282. 5. Fischer, T.V. and Floyd, a.D. 1972. Placental developmentin the Mongolian gerbil (Meriones unguiculatus) I. Early development to the time of chorio-allantoic contact. Am. J.Anat. 134: 309–320.6. Fochi, R.a., Perez, a.P.S., Bianchi, C.V., Rochel, S.S., Góes,R.M., Vilamaior, P.S.L., Taboga, S.R., and Santos, F.C.a.2008. Hormonal oscillations during the estrous cycle influence the morphophysiology of the gerbil (Meriones unguiculatus) female prostate (skene paraurethral glands).Biol. Reprod. 79: 1084–1091.7. Ford, J.J., Takahashi, M., Yoshinaga, K., and Greep, R.O.1975. Progestin levels after inhibition of postpartum ovulation in rats. Biol. Reprod. 12: 584–589.8. Hansen, S., Södersten, P., and Eneroth, P. 1983. Mechanismsregulating hormone release and the duration of dioestrus in the lactating rat. J. Endocrinol. 99: 173–180.9. Hashimoto, I., Hendricks, D.M., anderson, L.L., andMelampy, R.M. 1968. Progesterone and pregn-4-en-20α-ol-3-one in ovarian venous blood during various reproductive states in the rat. Endocrinology 82: 333–341.10. Honda, K., Sugawara, S., and Masaki, J. 1977. Serum Levelsof Progesterone, Prolactin, LH and FSH during Lactation in the Rat. Tohoku J. Agric. Res. 28: 135–144.11. Kai, O., Hiramatsu, Y., Sonoda, Y., Sensui, N., and Imai, K.1997. Plasma progesterone concentrations during pregnancy and lactation in mongolian gerbils (Meriones unguiculatus).Exp. Anim. 46: 283–288.12. Kai, O., Sonoda, Y., Sensui, N., and Imai, K. 1999. Effectof litter size on gestation length and plasma progesterone concentration in Mongolian gerbils (Meriones unguiculatus).Anim. Sci. J. 70: 18–23.13. Kinsley, C.H., Trainer, R., Stafisso-Sandoz, G., Quadros, P.,Marcus, L.K., Hearon, C., Meyera, E.a.a., Hestera, N., Morgana, M., Kozuba, F.J., and Lambertb, K.G. 2006.Motherhood and the hormones of pregnancy modify concentrations of hippocampal neuronal dendritic spines.Horm. Behav. 49: 131–142.14. Kuhn, N.J. 1969. Progesterone withdrawal as the lactogenictrigger in the rat. J. Endocrinol. 44: 39–54.15. Lephart, E.D., Simpson, E.R., and McPhaul, M.J. 1992.Ovarian aromatase cytochrome P-450 mRNa levels correlate with enzyme activity and serum estradiol levels in anestrous, pregnant and lactating rats. Mol. Cell. Endocrinol.85: 205–214.16. Lisk, R.D. 1978. The regulation of sexual “heat”. pp.425–466. In: Biological Determinants of Sexual Behavior (Hutchinson, J.B. ed.), Wiley, London.17. Luo, Z.X., Chen, W., Gao, W., Wang, Y.X., Li, C.Y., Li, H.,Huang, W.J., Lu, M.F., Wen, Y.X., Zhou, M.Z., Shou, Z.C., Zhang, W.S., and Hou, L.X. 2000. Rodentia Part III: Cricetidae. pp. 121–128. In: Fauna Sinica Mammalia, vol 6, Science Press, Beijing (in Chinese).18. Marston, J.H. and Chang, C. 1965. The breeding,management, and reproductive physiology of the Mongolian gerbil (Meriones unguiculatus). Lab. Anim. Care 15: 34–48.19. McDermott, J.L. and Carter, C.S. 1980. Ovarian hormones,copulatory stimuli, and female sexual behavior in the237 HORMONaL VaRIaTIONS aND REPRODUCTIVE STaTESMongolian gerbil. Horm. Behav. 14: 211–233.20. McCormack, J.T. and Greenwald, G.S. 1974. Progesteroneand oestradiol-17beta concentrations in the peripheral plasma during pregnancy in the mouse. J. Endocrinol. 62: 101–107.21. Neumann, K., Maak, S., Stuermer, I.W., von Lengerken, G.,and Gattermann, R. 2001. Low microsatellite variation in laboratory gerbils. J. Hered. 92: 71–74.22. Nishino, N. and Totsukawa, K. 1996. Study on the estrouscycle in the Mongolian gerbil (Meriones unguiculatus). Exp.Anim. 45: 283–288.23. Paris, J.J. and Frye, C.a. 2008. Estrous cycle, pregnancy,and parity enhance performance of rats in object recognition or object placement tasks. Reproduction 136: 105–115.24. Parkening, T.a., Collins, T.J., and Smith, E.R. 1984. Plasmaand pituitary concentrations of LH, FSH and prolactin in aging Mongolian gerbils. Exp. Gerontol. 19: 359–365. 25. Rothchild, I. 1981. The regulation of the mammalian corpusluteum. Recent Prog. Horm. Res. 37: 183–298.26. Shaikh, a.a. 1971. Estrone and estradiol levels in theovarian venous blood from rats during the estrous cycle and pregnancy. Biol. Reprod. 5: 297–307.27. Smith, M.S. 1984. Effects of the intensity of the sucklingstimulus and ovarian steroids on pituitary gonadotropin-releasing hormone receptors during lactation. Biol. Reprod.31: 548–555.28. Smith, M.S. and Neill, J.D. 1977. Inhibition of gonadotropinsecretion during lactation in the rat: relative contribution of suckling and ovarian steroids. Biol. Reprod. 17: 255–261.29. Staley, K. and Scharfman, H. 2005. a woman’s prerogative.Nature Neurosci. 8: 697–698.30. Taya, K. 1992. Studies on regulatory mechanisms forgonadotropins secretion in lactating rats. J. Reprod. Develop.38: J91–107.31. Tomogane, H., Ota, K., and Yokoyama, a. 1969. Progesteroneand 20α-hydroxy-pregn-4-en-3-one levels in ovarian vein blood of the rat throughout lactation. J. Endocrinol. 44: 101–106.32. Traurig, H.H. 1971. Epithelial cell proliferation in the mousevagina during the estrous cycle, pregnancy and lactation: a radioautographic study. Anat. Rec. 170: 457–470.33. Wu, J.T. 1975. Time of implantation in the Mongolian Gerbil(Meriones unguiculatus) and its hormonal requirements.Biol. Reprod. 13: 298–303.34. Yoshinaga, K., Moudgal, N.R., and Greep, R.O. 1971.Progestin secretion by the ovary in lactating rats: effect of LH-antiserum, LH and prolactin. Endocrinology88: 1126–1130.35. Zhao, K.T. 1960. The ecological observation of theMongolian gerbil (Meriones unguiculatus). Chinese J. Zool.4: 155–157 (in Chinese).。